<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-7402045834388658693</id><updated>2011-10-16T16:26:21.144+01:00</updated><category term='asma'/><category term='Rastreio'/><category term='H1N1'/><category term='lombalgia'/><category term='LABA'/><title type='text'>Para além do Horizonte</title><subtitle type='html'>O que aconteceu e o que vai acontecer.
Uma experiência de troca de informações e de conteúdos formativos para todos os profissionais da USF Horizonte.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default?start-index=101&amp;max-results=100'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>128</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7969046656190911506</id><published>2011-05-14T07:38:00.003+01:00</published><updated>2011-05-14T07:50:11.874+01:00</updated><title type='text'>Um novo contrato na definição de doença</title><content type='html'>Muitos dos painéis que são criados para definir e ampliar doenças estão muito ligados a empresas farmacêuticas &lt;br /&gt;Algumas vozes reclamam novas formas inovadoras de definir doenças, com novos tipos de painéis. &lt;br /&gt;Esses novos painéis deveriam ser independentes da indústria e totalmente livres de conflitos de interesse &lt;br /&gt;A constituição dos novos painéis poderia ser ampliada, mais representativa, com mais vozes de cidadãos &lt;br /&gt;As decisões deveriam ser baseadas na melhor evidência, incluindo provas sobre os determinantes sociais.&lt;br /&gt;&lt;br /&gt;A new deal on disease definition. Ray Moynihan&lt;br /&gt;&lt;a href="http://www.bmj.com/content/342/bmj.d2548.full.pdf"&gt;BMJ 2011;342:d2548 doi: 10.1136/bmj.d2548&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7969046656190911506?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7969046656190911506/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/um-novo-contrato-na-definicao-de-doenca.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7969046656190911506'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7969046656190911506'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/um-novo-contrato-na-definicao-de-doenca.html' title='Um novo contrato na definição de doença'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7613494841345213971</id><published>2011-05-06T17:25:00.000+01:00</published><updated>2011-05-06T17:26:16.776+01:00</updated><title type='text'>Respiratory Abstracts Review</title><content type='html'>Current Issue&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.theipcrg.org/mail/resp_ab_review/ipcrg_respiratory_abstract_review_21.pdf"&gt;Issue 21, May 2011&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7613494841345213971?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7613494841345213971/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/respiratory-abstracts-review.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7613494841345213971'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7613494841345213971'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/respiratory-abstracts-review.html' title='Respiratory Abstracts Review'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7483418017488391418</id><published>2011-05-06T17:17:00.001+01:00</published><updated>2011-05-06T17:22:46.601+01:00</updated><title type='text'>Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy</title><content type='html'>Study results at 2 months suggest that LTRA was equivalent to an inhaled glucocorticoid as first-line controller therapy and to LABA as add-on therapy for diverse primary care patients. Equivalence was not proved at 2 years.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1010846#t=articleTop "&gt;N Engl J Med 2011; 364:1695-1707&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7483418017488391418?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7483418017488391418/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/leukotriene-antagonists-as-first-line.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7483418017488391418'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7483418017488391418'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/leukotriene-antagonists-as-first-line.html' title='Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8493473348833864494</id><published>2011-05-05T07:34:00.003+01:00</published><updated>2011-05-05T07:39:56.150+01:00</updated><title type='text'>A evolução do médico baseado na evidência</title><content type='html'>Porque simplesmente está difícil cansar-me destes podcasts... e porque estes quase 45 minutos são uma muito interessante reflexão a três sobre a nossa prática clínica, aqui fica a recomendação de ouvir &lt;a href="http://therapeuticseducation.org/podcast/episode-122-evolution-evidence-based-doctor"&gt;"The evolution of an evidence-based doctor"&lt;/a&gt;, pelo grupo TEC.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8493473348833864494?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8493473348833864494/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/evolucao-de-medico-baseado-na-evidencu.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8493473348833864494'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8493473348833864494'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/05/evolucao-de-medico-baseado-na-evidencu.html' title='A evolução do médico baseado na evidência'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1593663903929628513</id><published>2011-03-27T19:47:00.003+01:00</published><updated>2011-03-27T19:54:18.419+01:00</updated><title type='text'>Lei do Tabaco</title><content type='html'>&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span"  style="font-family:arial;"&gt;A DGS publicou a primeira avaliação do impacto da aplicação da Lei do Tabaco&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span"  style="font-family:arial;"&gt; no &lt;a href="http://www.dgs.pt/upload/membro.id/ficheiros/i014123.pdf"&gt;&lt;span class="Apple-style-span"  style="color:#000000;"&gt;Infotabac Relatório&lt;/span&gt;&lt;/a&gt;. &lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span"  style="font-family:arial;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span class="Apple-style-span"  style="font-family:arial;"&gt;As conclusões parecem globalmente positivas, com uma diminuição dos fumadores passivos, do hábito de fumar dentro de casa e até do fumo activo.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1593663903929628513?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1593663903929628513/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/lei-do-tabaco.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1593663903929628513'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1593663903929628513'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/lei-do-tabaco.html' title='Lei do Tabaco'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2503229449073223600</id><published>2011-03-27T16:32:00.025+01:00</published><updated>2011-10-16T16:26:21.196+01:00</updated><title type='text'>Educação Médica Contínua 2011</title><content type='html'>&lt;span style="font-weight: bold; font-style: italic;"&gt;&lt;/span&gt;&lt;strong&gt;&lt;em&gt;17 Fevereiro 2011&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/view.aspx/Reuni%C3%B5es%20USF%20Horizonte%202011/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2017-02-11.docx"&gt;Tema&lt;/a&gt;&lt;/span&gt; &lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;br /&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;1. &lt;span style="font-style: italic;"&gt;Journal Club&lt;/span&gt; - Estudo original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;span style=" line-height: 150%; font-family:georgia;font-size:11pt;"  &gt;&lt;/span&gt;&lt;b&gt;Effects of common anti-epileptic drug monotherapy on serum levels oh homocysteine, vitamin B12, folic acid and vitamin B6&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Sener U, Zerlu Y, Karaguzel O, Ozdamar O, Coker I, Topbas M. Seizure. 2006 Mar;15(2):79-85&lt;/p&gt;&lt;span style="line-height: 150%; font-family: georgia;font-family:georgia;font-size:85%;"  &gt;Disponível em: &lt;/span&gt;&lt;span style="font-size:85%;"&gt;&lt;a style="font-family: georgia;" href="http://www.journals.elsevierhealth.com/periodicals/yseiz/article/S1059-1311%2805%2900217-7/abstract" target="_blank"&gt;&lt;span style=" line-height: 150%;"&gt;http://www.journals.elsevierhealth.com/periodicals/yseiz/article/S1059-1311(05)00217-7/abstract&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="line-height: 150%; font-family: georgia;font-family:georgia;font-size:85%;"  &gt; &lt;span style="mso-char-type:symbol;mso-symbol-"&gt;[&lt;/span&gt; acedido a 22/01/2011&lt;span style="mso-char-type:symbol;mso-symbol-"&gt;]&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:85%;"&gt; &lt;/span&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Diana Carneiro, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. Trabalho de Garantia da Qualidade:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="0" name="Hyperlink"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Tabela normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-qformat:yes;  mso-style-parent:"";  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;  mso-para-margin:0cm;  mso-para-margin-bottom:.0001pt;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-fareast-font-family:"Times New Roman";  mso-fareast-theme-font:minor-fareast;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/p&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Grau de satisfação dos utentes da USF Horizonte - Avaliação de 2010 e comparação com 2007&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Clara Pinto Ferreira, Alexandra Pina, Ana Figueiredo, Ana Margarida Cruz, Joana Melo Cabrita&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;USF Horizonte&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p  style="margin: 0cm 0cm 0pt;font-family:courier new;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;3. Caso clínico:&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Ansiedade ou algo mais?&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, Alexandra Pina&lt;br /&gt;USF Horizonte&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;23 Março 2011&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/view.aspx/Reuni%C3%B5es%20USF%20Horizonte%202011/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2023-03-11.docx"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;1. &lt;span style="font-style: italic;"&gt;Journal Club&lt;/span&gt; - Estudo original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;Prevalência da síndrome metabólica nos doentes com psoríase&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Artigo citado:&lt;b&gt; Prevalence of the metabolic syndrome in psoriasis.&lt;br /&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Love TJ, Qureshi AA, Karlson EW, Gelfand Jm, Choi HK. Arch Dermatol. Epub 2010 Dec 20&lt;br /&gt;&lt;/p&gt;&lt;span style="line-height: 150%; font-family: georgia;font-family:georgia;font-size:85%;"  &gt;Disponível em: &lt;/span&gt;&lt;span style=" line-height: 150%; font-family:georgia;font-size:11pt;"  &gt;&lt;/span&gt;&lt;a style="font-family: georgia;" href="http://archderm.ama-assn.org/cgi/reprint/archdermatol.2010.370v1%20"&gt;&lt;span style=" line-height: 150%;font-size:11pt;" &gt;http://archderm.ama-assn.org/cgi/reprint/archdermatol.2010.370v1&lt;/span&gt;&lt;/a&gt;&lt;span style=" line-height: 150%; font-family:georgia;font-size:11pt;"  &gt; [acedido a 20/03/2011]&lt;/span&gt;&lt;span style="font-family:georgia;font-size:85%;"&gt;&lt;a href="http://www.journals.elsevierhealth.com/periodicals/yseiz/article/S1059-1311%2805%2900217-7/abstract" target="_blank"&gt;&lt;span style=" line-height: 150%;"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Clara Pinto Ferreira, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;span style="line-height:150%;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font: minor-latinfont-family:&amp;quot;;font-size:11.0pt;"  &gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="line-height:150%;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font: minor-latinfont-family:&amp;quot;;font-size:11.0pt;"  &gt;&lt;/span&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. Estudo de investigação:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;  &lt;/p&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Capacitação e qualidade de vida em utentes asmáticos (Estudo EQLAP) um estudo transversal em Medicina Geral e Familiar&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, Jaime Correia de Sousa, Alexandra Pina, Ana Quelhas, Filipa Almada Lobo, Joana Melo Cabrita, John Yaphe &lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;em&gt;&lt;/em&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;USF Horizonte, ACES de Matosinhos, Saúde Comunitária, Escola de Ciências da Saúde, Universidade do Minho&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="0" name="Hyperlink"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Tabela normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-qformat:yes;  mso-style-parent:"";  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;  mso-para-margin:0cm;  mso-para-margin-bottom:.0001pt;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-fareast-font-family:"Times New Roman";  mso-fareast-theme-font:minor-fareast;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/p&gt;3. Panfleto:&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Início de Insulina, recomendações&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, USF Horizonte&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;19 Maio 2011&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/view.aspx/Reuni%C3%B5es%20USF%20Horizonte%202011/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2019-05-11.docx"&gt;Tema&lt;/a&gt;&lt;/span&gt; &lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;br /&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;1. Caso Clínico:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;"Recuso-me a ir para aquela escola"&lt;/b&gt;&lt;br /&gt;&lt;/p&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Diana Carneiro, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. Estudo de investigação:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;  &lt;/p&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;DPOC na população sob vigilância pela Rede Médicos Sentinela de 2007 a 2009&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Alexandra Pina,&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;USF Horizonte&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Dânia Ferreira, &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Raquel Figueiredo, Clara Pinto Ferreira, Joana Melo Cabrita, Jaime Correia de Sousa&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;14 Setembro 2011&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="https://skydrive.live.com/view.aspx?cid=4379A1A3078A50D3&amp;amp;resid=4379A1A3078A50D3%21168"&gt;Tema&lt;/a&gt;&lt;/span&gt; &lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;br /&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;1. &lt;span style="font-style: italic;"&gt;Journal Club&lt;/span&gt; - Estudo original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-Van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators. N Engl J Med. 2011 Mar 24;364(12):1093-1103. 2006 Mar;15(2):79-85&lt;br /&gt;&lt;/p&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. Planificação da Reunião Clínica do ACES de Matosinhos, de 23 de Setembro.&lt;br /&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2503229449073223600?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2503229449073223600/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/educacao-medica-continua-2011.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2503229449073223600'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2503229449073223600'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/educacao-medica-continua-2011.html' title='Educação Médica Contínua 2011'/><author><name>Clara Pinto Ferreira</name><uri>http://www.blogger.com/profile/15131505695620815048</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_84hiOEfnTh8/SxAU115XWZI/AAAAAAAAAAM/E00thOGyrTw/S220/Caves+Taylor%27s+(4).JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8335331743853708567</id><published>2011-03-26T13:05:00.002Z</published><updated>2011-03-26T13:13:36.017Z</updated><title type='text'>Tools for practice</title><content type='html'>&lt;div&gt;As &lt;a href="http://www.acfp.ca/tfp_original.php"&gt;"Tools for practice"&lt;/a&gt; são uma publicação quinzenal, que partem de uma pergunta clínica, procurando respostas sucintas e fáceis de entender, utilizando uma metodologia "baseada na evidência". &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;É um projecto do Alberta College of Familiy Physicians. E para quem é ouvinte dos TEC podcasts... é um projecto coordenado pelo Michael Allen.  &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8335331743853708567?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8335331743853708567/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/tools-for-practice.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8335331743853708567'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8335331743853708567'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/03/tools-for-practice.html' title='Tools for practice'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-908106656528399962</id><published>2011-02-02T11:24:00.001Z</published><updated>2011-02-02T11:24:32.529Z</updated><title type='text'>Declaração sobre a Política de Prevenção e Promoção de Saúde nos Cuidados de Saúde Primários</title><content type='html'>Esta &lt;a href="http://www.europrev.org/documents/FINAL%20POLICY%20STATEMENT.pdf"&gt;declaração &lt;/a&gt;foi desenvolvida pelo EUROPREV - Rede Europeia de Prevenção e Promoção da Saúde em Medicina Geral e Familiar e constituí uma declaração política sobre o tipo de actividades preventivas recomendadas e os cuidados a ter na adopção de recomendações oriundas de grupos de interesse e não baseados em evidências científicas.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-908106656528399962?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/908106656528399962/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/declaracao-sobre-politica-de-prevencao.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/908106656528399962'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/908106656528399962'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/declaracao-sobre-politica-de-prevencao.html' title='Declaração sobre a Política de Prevenção e Promoção de Saúde nos Cuidados de Saúde Primários'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-690264717912128980</id><published>2011-02-02T11:10:00.002Z</published><updated>2011-02-02T11:16:17.082Z</updated><title type='text'>Guia EUROPREV de Aconselhamento de Actividade Física na prática diária</title><content type='html'>Este folheto foi desenvolvido pelo EUROPREV - Rede Europeia de Prevenção e Promoção da Saúde em Medicina Geral e Familiar. O EUROPREV é a rede oficial de actividades preventivas dentro da WONCA Europa -  a filial regional da WONCA, a Organização Mundial de Médicos de Família. Este &lt;a href="http://www.europrev.org/documents/PhysicalActivityGuide.pdf"&gt;Guia de Aconselhamento de Actividade Física &lt;/a&gt;é destinado aos médicos de família que necessitem de um guia simples, pequeno e prático para o aconselhamento de actividade física para os seus doentes.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-690264717912128980?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/690264717912128980/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/guia-europrev-de-aconselhamento-de.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/690264717912128980'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/690264717912128980'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/guia-europrev-de-aconselhamento-de.html' title='Guia EUROPREV de Aconselhamento de Actividade Física na prática diária'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-9177330441049813953</id><published>2011-02-02T11:02:00.000Z</published><updated>2011-02-02T11:04:03.876Z</updated><title type='text'>Programa de Actividades Preventivas e de Promoção da Saúde – PAPPS</title><content type='html'>O PAPPS, Programa de Actividades Preventivas e de Promoção da Saúde, é um projecto da Sociedade Espanhola de Medicina Familiar e Comunitária (SEMFyC) que promove esse tipo de actividade nos centros de saúde. Este programa tem um acordo de cooperação com o Ministério da Saúde Espanhol, quase desde a sua fundação. Os objectivos do PAPS são: (1) Estimular a qualidade do atendimento nos cuidados primários para promover a integração de um programa de prevenção e promoção da saúde nas tarefas normalmente executadas nas de consultas de cuidados primários. (2) Identificar as dificuldades geradas pela sua implementação e identificar as necessidades de pessoal e infra-estrutura necessária para as realizar. (3) Gerar recomendações periódicas de prioridades de métodos de prevenção baseados em evidências científicas, dados de morbilidade, recursos disponíveis e os resultados das avaliações das actividades de prevenção de equipas de cuidados primários. (4) Promover a formação e a investigação sobre a prevenção nos cuidados primários na realização de projectos específicos relacionados com o programa.&lt;br /&gt;Os documentos que fundamentam as boas práticas de prevenção, baseadas em evidências podem ser lidas na &lt;a href="http://www.papps.org/index.php"&gt;página do PAPPS &lt;/a&gt;quer as &lt;a href="http://www.papps.org/suplemento_ap_09.php"&gt;versões longas&lt;/a&gt;, quer os &lt;a href="http://www.papps.org/resumen_recomendaciones.php"&gt;resumos&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-9177330441049813953?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/9177330441049813953/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/programa-de-actividades-preventivas-e.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9177330441049813953'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9177330441049813953'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/02/programa-de-actividades-preventivas-e.html' title='Programa de Actividades Preventivas e de Promoção da Saúde – PAPPS'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4502197208327956296</id><published>2011-01-25T11:07:00.003Z</published><updated>2011-01-25T11:26:18.444Z</updated><title type='text'>Novidades da ARS Norte</title><content type='html'>&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;Afinal não é só a &lt;a href="www.dgs.pt"&gt;DGS&lt;/a&gt; que nos tem brindado com novidades "normativas" neste início de 2011, também a ARS Norte emitiu circulares &lt;/span&gt;&lt;/span&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Documentos/Circulares%20da%20ARSNorte/Circulares%20Normativas%202011/Circular%20Normativa%201_2011.pdf"&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;normativas&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; (rastreio do cancro da mama) e &lt;/span&gt;&lt;/span&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Documentos/Circulares%20da%20ARSNorte/Circulares%20Informativas%202011"&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;informativas&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt; (menopausa e planeamento familiar e IVG).&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="font-family:verdana;"&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;A novidade é o rastreio do cancro da mama organizado, na zona norte, através de uma parceria com a Liga Portuguesa Contra o Cancro (população alvo - mulheres 45 a 65 anos).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4502197208327956296?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4502197208327956296/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/novidades-da-ars-norte.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4502197208327956296'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4502197208327956296'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/novidades-da-ars-norte.html' title='Novidades da ARS Norte'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6188255678168360605</id><published>2011-01-17T12:38:00.000Z</published><updated>2011-01-17T12:39:31.010Z</updated><title type='text'>Segurança cardiovascular dos AINE: uma meta análise</title><content type='html'>Apesar de permanecer a incerteza, existe escassa evidência que suporte a ideia que qualquer dos AINE seja seguro do ponto de vista cardiovascular. Isto deve ser tido em conta quando prescrevermos um anti-inflamatório.&lt;br /&gt;&lt;br /&gt;Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. &lt;a href="http://www.bmj.com/content/342/bmj.c7086.full.pdf"&gt;&lt;em&gt;&lt;strong&gt;Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis&lt;/strong&gt;&lt;/em&gt;&lt;/a&gt;. BMJ 342:doi:10.1136/bmj.c7086&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6188255678168360605?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6188255678168360605/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/seguranca-cardiovascular-dos-aine-uma.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6188255678168360605'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6188255678168360605'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/seguranca-cardiovascular-dos-aine-uma.html' title='Segurança cardiovascular dos AINE: uma meta análise'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5527100081243022005</id><published>2011-01-17T11:54:00.000Z</published><updated>2011-01-17T11:55:33.777Z</updated><title type='text'>IPCRG Users’ Guide to COPD “Wellness” Tools</title><content type='html'>O IPCRG Research Network reviu mais de 42 destes instrumentos e produziu um &lt;a href="http://www.theipcrg.org/resources/ipcrg_users_guide_to_copd_wellness_tools.pdf"&gt;guia prático &lt;/a&gt;que o ajuda a escolher o mais apropriado.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5527100081243022005?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5527100081243022005/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/ipcrg-users-guide-to-copd-wellness.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5527100081243022005'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5527100081243022005'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2011/01/ipcrg-users-guide-to-copd-wellness.html' title='IPCRG Users’ Guide to COPD “Wellness” Tools'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8536186413081398216</id><published>2010-12-01T19:25:00.004Z</published><updated>2010-12-01T19:40:36.838Z</updated><title type='text'>RCP</title><content type='html'>A European Resuscitation Council (ERC) publicou as novas orientações clínicas para SBV e SAV.&lt;br /&gt;Está disponível &lt;a href="http://resuscitation-guidelines.articleinmotion.com/article/S0300-9572%2810%2900435-1/aim/"&gt;no site &lt;/a&gt;um video muito simples que explica as alterações ao anterior documento de 2005.&lt;br /&gt;Entre várias recomendações, o ênfase vai para as compressões torácicas, com a importância de serem bem realizadas, pelo menos 5 cm de depressão torácica.&lt;br /&gt;Para um leigo/ ou na impossibilidade de ventilar, o mais importante é realizar as compressões a uma frequência de 100/min.&lt;br /&gt;Mantem-se a regra das 30 compressões: 2 ventilações.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8536186413081398216?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8536186413081398216/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/12/rcp.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8536186413081398216'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8536186413081398216'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/12/rcp.html' title='RCP'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6301229138342155960</id><published>2010-11-21T18:34:00.002Z</published><updated>2010-11-21T18:40:34.371Z</updated><title type='text'>Asma</title><content type='html'>Porque nunca é demais rever os artigos sobre o tema.&lt;br /&gt;Este grupo canadiano, Therapeutics Education Collaboration (TEC), constituído por um farmacêutico e um médico de família faz uma abordagem clara, precisa e divertida sobre o tema.&lt;br /&gt;Existem muitos mais podcasts que recomendo vivamente, mas fica aqui o que mais recente sobre a terapêutica &lt;a href="http://therapeuticseducation.org/2010/11/10/episode-104-a-high-dose-of-acute-asthma-therapeutics/"&gt;aguda na asma&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6301229138342155960?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6301229138342155960/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/11/asma.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6301229138342155960'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6301229138342155960'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/11/asma.html' title='Asma'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2936969676205803752</id><published>2010-09-25T06:55:00.001+01:00</published><updated>2010-09-25T07:05:21.866+01:00</updated><title type='text'>A FDA anuncia novas restrições à Rosiglitazona. A Europa suspende o fármaco.</title><content type='html'>&lt;a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226994.htm"&gt;A FDA notificou&lt;/a&gt; os profissionais de saúde e doentes que iria restringir significativamente o uso da Rosiglitazona aos doentes com Diabetes Tipo 2. Estas novas restrições surgem como resposta aos dados que sugerem a existência de um risco de eventos cardiovasculares tais como EAM e AVC nos doentes tratados com Rosiglitazona.&lt;br /&gt;&lt;br /&gt;A decisão da European Medicines Agency (EMA) foi no sentido de &lt;a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/09/news_detail_001119.jsp&amp;amp;murl=menus/news_and_events/news_and_events.jsp&amp;amp;mid=WC0b01ac058004d5c1&amp;amp;jsenabled=true"&gt;suspender a autorização&lt;/a&gt; de comercialização dos medicamentos contendo Rosiglitazona ( Avandia e Avandamet).&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2936969676205803752?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2936969676205803752/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/fda-anuncia-novas-restricoes.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2936969676205803752'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2936969676205803752'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/fda-anuncia-novas-restricoes.html' title='A FDA anuncia novas restrições à Rosiglitazona. A Europa suspende o fármaco.'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1637068003233140260</id><published>2010-09-24T10:02:00.000+01:00</published><updated>2010-09-24T10:11:38.769+01:00</updated><title type='text'>Vacinação contra a gripe com a vacina trivalente na época 2010/2011</title><content type='html'>&lt;p&gt;A DGS publicou em 22/9/2010 uma &lt;a href="http://www.dgs.pt/?cr=16640"&gt;orientação &lt;/a&gt;sobre vacinação contra a gripe na época 2010/2011&lt;br /&gt;&lt;br /&gt;Os grupos‐alvo prioritários para vacinação são: &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Pessoas com idade igual ou superior a 65 anos; &lt;/li&gt;&lt;li&gt;Doentes crónicos e imunodeprimidos, com mais de 6 meses de idade; &lt;/li&gt;&lt;li&gt;Grávidas com tempo de gestação superior a 12 semanas; &lt;/li&gt;&lt;li&gt;Profissionais de saúde e outros prestadores de cuidados (lares de idosos, designadamente). &lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1637068003233140260?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1637068003233140260/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/vacinacao-contra-gripe-com-vacina.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1637068003233140260'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1637068003233140260'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/vacinacao-contra-gripe-com-vacina.html' title='Vacinação contra a gripe com a vacina trivalente na época 2010/2011'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6194056505153445979</id><published>2010-09-20T19:44:00.001+01:00</published><updated>2010-09-20T19:47:29.462+01:00</updated><title type='text'>Ainda o PSA e o rastreio do cancro da próstata</title><content type='html'>Um artigo de revisão sistemática recentemente publicado no BMJ refere que a evidência existente proveniente dos estudos controlados aleatorizados não apoia a rotina de se rastrear o cancro da próstata com o PSA com ou sem toque rectal.&lt;br /&gt;&lt;br /&gt;Djulbegovic M, Beyth RB, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al. &lt;a href="http://www.bmj.com/content/341/bmj.c4543.full.pdf"&gt;Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. &lt;/a&gt;BMJ2010;341:c4543.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6194056505153445979?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6194056505153445979/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/ainda-o-psa-e-o-rastreio-do-cancro-da.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6194056505153445979'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6194056505153445979'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/ainda-o-psa-e-o-rastreio-do-cancro-da.html' title='Ainda o PSA e o rastreio do cancro da próstata'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-873109555893587222</id><published>2010-09-05T09:18:00.002+01:00</published><updated>2010-09-05T09:35:06.088+01:00</updated><title type='text'>Colchicina em baixa dose... e as maravilhas da indústria farmacêutica</title><content type='html'>Todas as semanas no &lt;a href="http://www.essentialevidenceplus.com/"&gt;Essential Evidence&lt;/a&gt; temos acesso, gratuitamente, a podcasts com POEMs úteis. Recentemente os autores discutiram um estudo em que o uso de colchicina em baixa dose foi tão eficaz como o uso da dose tradicional, tendo no entanto menos efeitos laterais. &lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Mas se os resultados são interessantes, é ainda mais a discussão posterior acerca da relação entre um dos autores do estudo e a indústria farmacêutica. Dá que pensar...&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Podem ouvir o podcast &lt;a href="http://www.essentialevidenceplus.com/netcasts/ipweekly_ep129.mp3"&gt;aqui&lt;/a&gt;!&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-873109555893587222?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/873109555893587222/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/colchicina-em-baixa-dose-e-as.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/873109555893587222'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/873109555893587222'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/colchicina-em-baixa-dose-e-as.html' title='Colchicina em baixa dose... e as maravilhas da indústria farmacêutica'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2247711127372329563</id><published>2010-09-04T11:25:00.003+01:00</published><updated>2010-09-04T11:32:24.702+01:00</updated><title type='text'>CDC - Pneumo 23 update</title><content type='html'>&lt;div&gt;O CDC publicou novas &lt;a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5934a3.htm"&gt;recomendações para vacinação de adultos com a Pneumo23&lt;/a&gt;, passando a incluir indivíduos fumadores e com asma.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2247711127372329563?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2247711127372329563/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/cdc-pneumo-23-update.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2247711127372329563'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2247711127372329563'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/09/cdc-pneumo-23-update.html' title='CDC - Pneumo 23 update'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1772254435062866096</id><published>2010-08-09T10:56:00.001+01:00</published><updated>2010-08-09T10:56:53.623+01:00</updated><title type='text'>Apresentada Estratégia de Vacinação Contra a Gripe</title><content type='html'>Foi apresentada a 4 de Agosto a &lt;a href="http://www.portaldocidadao.pt/PORTAL/pt/noticias/08_2010/NEWS_apresentada+estrategia+de+vacinacao+contra+a+gripe.htm"&gt;estratégia de vacinação&lt;/a&gt; que prevê a distribuição gratuita da vacina contra a gripe sazonal a um grupo específico de portugueses, assim como o aumento do número de pessoas vacinadas.&lt;br /&gt;&lt;br /&gt;Leia mais sobre o &lt;a href="http://www.portugal.gov.pt/pt/GC18/Governo/Ministerios/MS/Intervencoes/Pages/20100804_MS_Int_Gripe.aspx"&gt;alargamento da cobertura da protecção contra a gripe&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1772254435062866096?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1772254435062866096/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/08/apresentada-estrategia-de-vacinacao.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1772254435062866096'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1772254435062866096'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/08/apresentada-estrategia-de-vacinacao.html' title='Apresentada Estratégia de Vacinação Contra a Gripe'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-516414417067771823</id><published>2010-06-30T09:27:00.003+01:00</published><updated>2010-06-30T09:33:10.456+01:00</updated><title type='text'>Orientações terapêuticas para resultados complementares da colpocitologia</title><content type='html'>Estão disponíveis no sítio da ARS Norte as &lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Conte%C3%BAdos/Documentos/CI6.pdf"&gt;Orientações terapêuticas para resultados complementares da colpocitologia&lt;/a&gt; de rastreio do cancro do colo do útero, que acompanham o resultado negativo para lesão intraepitelial ou malignidade. O documento é da responsabilidade do Dr. José Maria Moutinho, membro do Grupo de trabalho do Rastreio do cancro do colo do útero da Comissão Oncológica Regional da ARS.&lt;br /&gt;&lt;br /&gt;Trata-se de um documento muito útil para a prática clínica diária e que poderá vir a padronizar as atitudes face aos resultados das citologias ao abrigo do novo &lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Conte%C3%BAdos/Planeamento%20Estrategico/Rastreios/RCCU%20-%20Programa.pdf"&gt;Programa do RCCU da Região Norte&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;Apesar destas considerações, lamenta-se o facto do documento não ter qualquer referência bibliográfica nem mencionar os níveis de evidência que suportam as recomendações, como, aliás, é prática corrente nos documentos análogos produzidos por organismos oficiais de outros países.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-516414417067771823?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/516414417067771823/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/orientacoes-terapeuticas-para.html#comment-form' title='1 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/516414417067771823'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/516414417067771823'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/orientacoes-terapeuticas-para.html' title='Orientações terapêuticas para resultados complementares da colpocitologia'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6486713739603327753</id><published>2010-06-27T07:52:00.000+01:00</published><updated>2010-06-27T07:53:08.055+01:00</updated><title type='text'>INSA disponibiliza Tabela de Alimentos Online</title><content type='html'>O &lt;a title="Link para Site do INSA" href="http://www.insa.pt/sites/INSA/Portugues/ComInf/Noticias/Paginas/LancamentoTabelaAlimentos.aspx" target="_blank"&gt;Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA)&lt;/a&gt; disponibilizou a Tabela da Composição dos Alimentos para consulta gratuita online.&lt;br /&gt;&lt;br /&gt;A &lt;a title="Link para Tabela da Composição de Alimentos" href="http://www.insa.pt/sites/INSA/Portugues/AreasCientificas/AlimentNutricao/AplicacoesOnline/TabelaAlimentos/PesquisaOnline/Paginas/PorPalavraChave.aspx" target="_blank"&gt;Tabela da Composição dos Alimentos&lt;/a&gt;, considerada uma referência nacional, divulga dados referentes a energia, macroconstituintes, ácidos gordos, colesterol, vitaminas e minerais de alimentos crus, cozinhados e processados. A pesquisa pode ser efectuada por palavra-chave, grupo de alimentos, componentes ou ordem alfabética.&lt;br /&gt;&lt;br /&gt;Esta ferramenta foi publicada em 2006, com dados de vários estudos realizados nos Laboratórios do Departamento de Alimentação e Nutrição (DAN) do INSA e pelo Instituto de Investigação das Pescas e do Mar (IPIMAR), e permite localizar com facilidade alimentos e componentes considerados prioritários pelas entidades mundiais.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6486713739603327753?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6486713739603327753/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/insa-disponibiliza-tabela-de-alimentos.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6486713739603327753'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6486713739603327753'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/insa-disponibiliza-tabela-de-alimentos.html' title='INSA disponibiliza Tabela de Alimentos Online'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6101759734725885647</id><published>2010-06-27T07:44:00.001+01:00</published><updated>2010-06-27T07:46:53.378+01:00</updated><title type='text'>Nova Comissão para Cuidados Respiratórios Domiciliários</title><content type='html'>Foi publicado em Diário da República (DR) o &lt;a title="Link para Despacho n.º 10336/2010" href="http://dre.pt/util/getpdf.asp?s=rss&amp;amp;serie=2&amp;amp;iddr=118.2010&amp;amp;iddip=2010033991" target="_blank"&gt;Despacho n.º 10336/2010&lt;/a&gt; de 21 de Junho, que determina a criação de uma Comissão Nacional para os Cuidados Respiratórios Domiciliários (CNCRD).&lt;br /&gt;&lt;br /&gt;Tendo em conta que as patologias do foro respiratório atingem um grande número de portugueses, a CNCRD pretende assegurar um tratamento adequado a todos os que necessitem, garantindo todos os recursos e uma rigorosa gestão dos dinheiros públicos.&lt;br /&gt;&lt;br /&gt;Os tratamentos envolvem terapias de forma continuada ou esporádica e incluiem o uso de terapêuticas como a oxigenoterapia, aerosolterapia e ventiloterapia. Os custos destes tratamentos serão suportados pelo Serviço Nacional de Saúde (SNS).&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6101759734725885647?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6101759734725885647/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/nova-comissao-para-cuidados.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6101759734725885647'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6101759734725885647'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/nova-comissao-para-cuidados.html' title='Nova Comissão para Cuidados Respiratórios Domiciliários'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3872641355344631635</id><published>2010-06-23T19:51:00.001+01:00</published><updated>2010-06-23T19:57:06.005+01:00</updated><title type='text'>Prontuário Terapêutico</title><content type='html'>Já está disponível online na página do &lt;a href="http://www.infarmed.pt/portal/page/portal/INFARMED"&gt;Infarmed &lt;/a&gt;a edição de Março de 2010 do &lt;a href="http://www.infarmed.pt/portal/page/portal/INFARMED/PUBLICACOES/PRONTUARIO/PT9_completo.pdf"&gt;Prontuário Terapêutico&lt;/a&gt; que está &lt;a href="http://www.infarmed.pt/prontuario/index.php"&gt;disponível online&lt;/a&gt;. Existe igualmente uma &lt;a href="http://www.infarmed.pt/portal/page/portal/35F0A1557C9A0523E044001321BEA04D"&gt;versão para Pocket PC &lt;/a&gt;disponível para Download.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3872641355344631635?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3872641355344631635/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/prontuario-terapeutico.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3872641355344631635'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3872641355344631635'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/prontuario-terapeutico.html' title='Prontuário Terapêutico'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2797455334832683559</id><published>2010-06-01T11:11:00.000+01:00</published><updated>2010-06-01T11:12:50.398+01:00</updated><title type='text'>Mais evidência contra o conceito de Sindroma Metabólico</title><content type='html'>Os doentes com Sindroma Metabólico não têm maior risco de EAM do que os que têm diabetes ou HTA isoladas.&lt;br /&gt;&lt;br /&gt;&lt;a name="bib_1"&gt;&lt;/a&gt;&lt;em&gt;Mente A, Yusuf S, Islam S, et al. &lt;strong&gt;Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26 903 subjects from 52 countries&lt;/strong&gt;. J Am Coll Cardiol 2010; 55:2390-2398. &lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;Enquanto o artigo não está disponível para leitura integral , pode ler o &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/20488312?dopt=Abstract"&gt;resumo&lt;/a&gt;, ou um &lt;a href="http://www.medscape.com/viewarticle/722203?src=mpnews&amp;amp;spon=34&amp;amp;uac=25019HT"&gt;comentário&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2797455334832683559?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2797455334832683559/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/mais-evidencia-contra-o-conceito-de.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2797455334832683559'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2797455334832683559'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/mais-evidencia-contra-o-conceito-de.html' title='Mais evidência contra o conceito de Sindroma Metabólico'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1368429601048271588</id><published>2010-06-01T10:49:00.003+01:00</published><updated>2010-06-01T10:52:10.026+01:00</updated><title type='text'>Ranking SCImago</title><content type='html'>Foi publicado o Ranking Iberoamericano SIR2010, que procura avaliar aspectos relativos à dimensão, rendimento, impacto científico e grau de internacionalização das instituições de ensino superior iberoamericanas.&lt;br /&gt;&lt;a href="http://www.freescienceinformation.com/index.php?option=com_content&amp;amp;view=article&amp;amp;id=129:ranking-scimago&amp;amp;catid=74:gerais&amp;amp;Itemid=95"&gt;Ler mais &gt;&gt;&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1368429601048271588?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1368429601048271588/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/ranking-scimago.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1368429601048271588'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1368429601048271588'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/06/ranking-scimago.html' title='Ranking SCImago'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8807285917656806453</id><published>2010-05-26T15:09:00.000+01:00</published><updated>2010-05-26T15:10:15.752+01:00</updated><title type='text'>O que é o movimento Healthy Skepticism?</title><content type='html'>O que é o movimento &lt;a href="http://www.healthyskepticism.org/global/"&gt;Healhy Skepticism&lt;/a&gt;?&lt;br /&gt;Objectivos:&lt;br /&gt;1. Melhorar a saúde através da redução dos efeitos nocivos causados pelas práticas de marketing de produtos e serviços de saúde inapropriadas, enganosas ou não éticas, sobretudo a promoção enganosa da Indústria.2. Investigação e divulgação sobre práticas de marketing.&lt;br /&gt;3. Promoção do trabalho da Healthy Skepticism através de actividades de apoio, investigação e formação.&lt;br /&gt;4. Desenvolvimento, apoio e avaliação de iniciativas que contrariem as práticas lesivas de marketing.&lt;br /&gt;5. Desenvolvimento, implementação e avaliação de estratégias formativas com vista à melhoria do processo de tomada de decisões a nível dos cuidados de saúde.&lt;br /&gt;6. Apoio à prestação de cuidados de saúde baseados na evidência que sejam humanizados, apropriados e sustentáveis. Estes cuidados devem ser prestados de acordo com a necessidade, de forma a atingir os melhores resultados possíveis. 7. Contribuir com oportunidades práticas para concretizar os objectivos da Healthy Skepticism.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8807285917656806453?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8807285917656806453/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/o-que-e-o-movimento-healthy-skepticism.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8807285917656806453'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8807285917656806453'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/o-que-e-o-movimento-healthy-skepticism.html' title='O que é o movimento Healthy Skepticism?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8462287838054203905</id><published>2010-05-26T15:06:00.002+01:00</published><updated>2010-05-26T15:08:11.517+01:00</updated><title type='text'>Seminário com Peter Mansfield</title><content type='html'>&lt;p&gt;&lt;span style="font-size:130%;color:#000066;"&gt;Educação médica, formação contínua e investigação pela indústria farmacêutica&lt;br /&gt;É possível fazer melhor!&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Os médicos são influenciados pela promoção da indústria farmacêutica?&lt;/li&gt;&lt;li&gt;Como é que funciona a promoção da indústria farmacêutica?&lt;/li&gt;&lt;li&gt;A promoção da indústria farmacêutica é mais benéfica que lesiva?&lt;/li&gt;&lt;li&gt;Quais são os recursos de formação contínua melhores e mais adequados que os médicos Portugueses podiam utilizar?&lt;/li&gt;&lt;li&gt;O que é que são boletins farmacoterapêuticos independentes e porque é que Portugal deve criar os seus próprios boletins?&lt;/li&gt;&lt;li&gt;O dinheiro da indústria farmacêutica é importante e vital para a investigação médica?&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;Data e local:&lt;br /&gt;Porto, 11 de Outubro de 2010, 18 h&lt;br /&gt;Salão Nobre da Secção Regional Norte da Ordem dos Médicos&lt;br /&gt;(Rua Delfim Maia, 405, Porto)&lt;br /&gt;Carga horária: 2 horas (das 18h às 20h)&lt;br /&gt;Entidade promotora: &lt;a href="http://www.healthyskepticism.org/global/"&gt;Healhy Skepticism&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8462287838054203905?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8462287838054203905/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/seminario-com-peter-mansfield.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8462287838054203905'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8462287838054203905'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/seminario-com-peter-mansfield.html' title='Seminário com Peter Mansfield'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4047360145167562740</id><published>2010-05-24T10:32:00.002+01:00</published><updated>2010-05-24T10:38:16.213+01:00</updated><title type='text'>USPSTF Clinical Preventive Services</title><content type='html'>&lt;a href="http://www.ahrq.gov/clinic/pocketgd09/pocketgd09.pdf"&gt;The Guide to Clinical Preventive Services 2009&lt;/a&gt; pode ser lido, para além de muitos outros documentos de interesse, na página do &lt;a href="http://www.ahrq.gov/clinic/uspstfix.htm"&gt;U.S. Preventive Services Task Force&lt;/a&gt; (USPSTF)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4047360145167562740?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4047360145167562740/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/uspstf-clinical-preventive-services.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4047360145167562740'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4047360145167562740'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/uspstf-clinical-preventive-services.html' title='USPSTF Clinical Preventive Services'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-257586649818002727</id><published>2010-05-15T10:58:00.001+01:00</published><updated>2010-05-15T10:59:38.040+01:00</updated><title type='text'>Como usar um debitómetro</title><content type='html'>Observe um &lt;a href="http://www.youtube.com/watch?v=dPDHsReZfQ0&amp;amp;NR=1"&gt;vídeo&lt;/a&gt; e uma &lt;a href="http://www.youtube.com/watch?v=yur0hZhDO-8&amp;amp;NR=1"&gt;animação&lt;/a&gt; que explicam a forma correcta de usar um debitómetro (Peak Flow Meter).&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-257586649818002727?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/257586649818002727/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/como-usar-um-debitometro.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/257586649818002727'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/257586649818002727'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/como-usar-um-debitometro.html' title='Como usar um debitómetro'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5213050022330376217</id><published>2010-05-15T10:09:00.003+01:00</published><updated>2010-05-15T11:01:17.496+01:00</updated><title type='text'>Como usar diferentes dispositivos inalatórios</title><content type='html'>&lt;span style="font-size:130%;"&gt;Dispositivos inalatórios e doenças respiratórias &lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:130%;"&gt;&lt;br /&gt;&lt;/span&gt;Observe estes vídeos onde se explica o uso correcto de alguns dispositivos inalatórios: &lt;a href="http://www.youtube.com/watch?v=h0orE3L5YSs"&gt;Inalador pressurizado&lt;/a&gt;, &lt;a href="http://www.youtube.com/watch?v=5BlQzzLsxno&amp;amp;feature=channel"&gt;Aerochamber&lt;/a&gt;, &lt;a href="http://www.youtube.com/watch?v=sJdG-c6y84I"&gt;Turbohaler©&lt;/a&gt;, diferentes tipos de &lt;a href="http://www.youtube.com/watch?v=tNL_lWfIHd8&amp;amp;NR=1"&gt;Turbohaler©&lt;/a&gt; , &lt;a href="http://www.youtube.com/watch?v=PJNowG6_CZo"&gt;Diskus©&lt;/a&gt;, &lt;a href="http://www.youtube.com/watch?v=-PFodgl8wcE"&gt;Novolizer©&lt;/a&gt;, &lt;a href="http://www.youtube.com/watch?v=zJxjfwB6uPg"&gt;Aerolizer©&lt;/a&gt; e &lt;a href="http://www.youtube.com/watch?v=fL0E4BG_MCU&amp;amp;feature=channel"&gt;HandiHaler©.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5213050022330376217?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5213050022330376217/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/como-usar-um-inalador-pressurizado.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5213050022330376217'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5213050022330376217'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/como-usar-um-inalador-pressurizado.html' title='Como usar diferentes dispositivos inalatórios'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-9179520903527532641</id><published>2010-05-13T16:02:00.003+01:00</published><updated>2010-05-13T16:12:31.775+01:00</updated><title type='text'>Vamos parar este massacre</title><content type='html'>Todos os anos morrem milhares de pessoas nas estradas Portuguesas. Vejam como a Austrália tenta lidar com o problema.&lt;br /&gt;Um &lt;a href="http://www.youtube.com/watch?v=Z2mf8DtWWd8"&gt;vídeo&lt;/a&gt; chocante mas de grande impacto.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-9179520903527532641?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/9179520903527532641/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/vamos-parar-este-massacre.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9179520903527532641'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9179520903527532641'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/05/vamos-parar-este-massacre.html' title='Vamos parar este massacre'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6272069848490173575</id><published>2010-04-15T18:42:00.040+01:00</published><updated>2011-01-23T11:43:32.673Z</updated><title type='text'>Educação Médica Contínua 2010</title><content type='html'>&lt;strong&gt;&lt;em&gt;26 Janeiro 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2026-01-10.doc"&gt;Tema&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt; &lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;i&gt;Journal Club&lt;/i&gt; – Estudo original:&lt;br /&gt;&lt;b&gt;Efeitos da administração de paracetamol profilático nas reacções febris e na resposta imunológica aquando da vacinação em crianças&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L. Lancet. 2009 Oct 17;374(9698):1339-50&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Disponível em:&lt;span style="font-family:times new roman;"&gt; &lt;/span&gt;&lt;a style="font-family: times new roman;" href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2961208-3/abstract"&gt;http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2961208-3/abstract&lt;/a&gt;&lt;span style="font-family:times new roman;"&gt; [acedido a 01/12/2009]&lt;/span&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Joana Melo Cabrita, USF Horizonte&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. &lt;i&gt;Journal Club&lt;/i&gt; – Estudo original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Acute cooling of the feet and the onset of common cold symptoms &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Johnson C, Eccles R. Family practice 2005; 22: 608-613&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Disponível em: &lt;a href="http://fampra.oxfordjournals.org/cgi/content/full/22/6/608" target="_blank"&gt;http://fampra.oxfordjournals.org/cgi/content/full/22/6/608&lt;/a&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Maria Espírito Santo, USF Horizonte&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p  style="margin: 0cm 0cm 0pt;font-family:courier new;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;3. Estudo de investigação:&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;A Diabetes Mellitus tipo 2, sua terapêutica e complicações: um estudo de follow-up&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Luís Sousa, aluno do 6º ano do Mestrado Integrado em Medicina da Universidade do Minho&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;29 Abril 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2029-04-10.doc"&gt;Tema&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;1. &lt;/span&gt;&lt;i&gt;Journal  Club&lt;/i&gt; – Estudo original:&lt;br /&gt;&lt;b&gt;Asma, Gravidez e Medicação&lt;/b&gt;&lt;span style="font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;Belanger K &lt;span style="font-style: italic;"&gt;et al&lt;/span&gt;. Effect on pregnancy on maternal asthma symptoms and medication use. Obstet Gynecol 2010 Mar; 115:559&lt;span style="line-height: 150%;font-family:Arial;font-size:10pt;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Joana Melo Cabrita, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. &lt;i&gt;Journal Club&lt;/i&gt; – Estudo  original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Em que base científica se recomenda a auto-monitorização glicémica?&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 11"&gt;&lt;meta name="Originator" content="Microsoft Word 11"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CClarinha%5CDEFINI%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;  &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" latentstylecount="156"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman";} a:link, span.MsoHyperlink 	{color:blue; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{color:purple; 	text-decoration:underline; 	text-underline:single;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman"; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style="line-height: 150%;font-family:Arial;font-size:10pt;"  lang="EN-GB" &gt;&lt;/span&gt;&lt;span style=";font-family:Arial;font-size:10pt;"  &gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Kolb H &lt;span style="font-style: italic;"&gt;et al&lt;/span&gt;. On what evidence-base do we recommend self-monitoring of blood glucose? Diabetes Res Clin Pract. 2010 Feb;87 (2):150-6. Epub 2009 Nov 18.&lt;/p&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Clara Pinto Ferreira , USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;3. Revisão de Tema&lt;br /&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Lombalgia Aguda.&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, USF  Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;4. Estudo de investigação:&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Apresentação do protocolo de investigação "Avaliação da satisfação dos utentes 2010".&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;span&gt;Joana Melo Cabrita&lt;/span&gt;,&lt;span style="font-weight: bold;"&gt; &lt;/span&gt;Alexandra Pina, Ana Figueiredo, Clara Pinto Ferreira&lt;br /&gt;USF Horizonte&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;20 Maio 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2020-05-10.doc"&gt;Tema&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;1. &lt;/span&gt;&lt;i&gt;Journal  Club&lt;/i&gt; – Estudo original:&lt;br /&gt;&lt;b&gt;Relation between kidney function, proteinuria, and adverse outcomes.&lt;/b&gt;&lt;span style="font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 415 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman";} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:10.0pt; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt;} @page WordSection1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.WordSection1 	{page:WordSection1;} --&gt; &lt;/style&gt;JAMA. 2010;303(5):423-429&lt;span style="line-height: 150%;font-family:Arial;font-size:10pt;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. &lt;i&gt;Journal Club&lt;/i&gt; – Estudo  original:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 415 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman";} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:10.0pt; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt;} @page WordSection1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.WordSection1 	{page:WordSection1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style="line-height: 150%;font-family:&amp;quot;;font-size:10pt;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;  &lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;The ACCORD study group. Effects on Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus.&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 11"&gt;&lt;meta name="Originator" content="Microsoft Word 11"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CClarinha%5CDEFINI%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;  &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" latentstylecount="156"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman";} a:link, span.MsoHyperlink 	{color:blue; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{color:purple; 	text-decoration:underline; 	text-underline:single;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman"; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} &lt;/style&gt; &lt;![endif]--&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;N Engl J Med 2010;362:1575-85.&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;Disponível em http://content.nejm.org/cgi/content/short/362/17/1575 &lt;span style="line-height: 150%;font-family:&amp;quot;;font-size:10pt;"  &gt;[acedido a 12/05/2010&lt;/span&gt;&lt;span style="line-height: 150%;font-family:&amp;quot;;font-size:10pt;"  &gt;]&lt;/span&gt;&lt;/p&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;3. Revisão baseada na Evidência&lt;br /&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Arando na profilaxia das Infecções Urinárias Recorrentes. &lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Alexandra Pina, &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Campos, &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, Clara Pinto Ferreira&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;, Irene Lopes, Isabel Ribeiro, Nuno Figueiras Alves&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;23 Setembro 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2023-09-10.doc"&gt;&lt;span lang="EN-GB"&gt;Tema&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span lang="EN-GB"&gt;1. &lt;/span&gt;&lt;i&gt;Journal Club&lt;/i&gt;&lt;br /&gt;&lt;b&gt;Vitamin D Treatment for the prevention of falls in older adults: Systematic Review and Meta-Analysis &lt;/b&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;J Am Geriatr Soc July 2010; 58(7):1299-1310. &lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="0" name="Hyperlink"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style=";font-family:&amp;quot;;font-size:10pt;"  &gt;&lt;/span&gt;&lt;/p&gt;&lt;span style=";font-family:&amp;quot;;font-size:10pt;"  lang="EN-US" &gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Alexandra Pina, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span lang="EN-GB"&gt;2. &lt;/span&gt;&lt;span style="font-style: italic;"&gt;Relato de Caso&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;"Doutor, estou a emagrecer..."&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Clara Pinto Ferreira, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;3. Revisão baseada na Evidência&lt;br /&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Uso de fitoestrogénios no tratamento dos sintomas vasomotores da menopausa.&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, Isabel Ribeiro, Sandrina Rodrigues &lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;4. Estudo de investigação:&lt;br /&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Prevalência de asma por grupos etários e sexo na população de Matosinhos&lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Jaime Correia de Sousa, Maria Espírito Santo, Tânia Colaço, Filipa Almada-Lobo, Yonah Yaphe&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;27 Outubro 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2027-10-10.doc"&gt;Tema&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span lang="EN-GB"&gt;1. &lt;/span&gt;&lt;i&gt;&lt;/i&gt;Estudo original - Avaliação da Qualidade:&lt;br /&gt;&lt;b&gt;Procedimentos Preventivos em Adultos Jovens - Garantia da Qualidade&lt;/b&gt;&lt;br /&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Joana Melo Cabrita, USF Horizonte; Ana Bessa Monteiro, USF Serpa Pinto; Ana Guimarães, USF Oceanos; Pedro Silva Almeida, UCSP Modivas&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;2. &lt;i&gt;Partilha de experiências - Visita de estudo a Newcastle&lt;/i&gt;:&lt;/p&gt;&lt;p style="margin: 0cm 0cm 0pt;"&gt;&lt;style&gt;p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }a:link, span.MsoHyperlink { color: blue; text-decoration: underline; }a:visited, span.MsoHyperlinkFollowed { color: purple; text-decoration: underline; }div.Section1 { page: Section1; }&lt;/style&gt;&lt;/p&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;24 Novembro 2010&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://cid-4379a1a3078a50d3.office.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202010/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2024-11-10.doc"&gt;&lt;span lang="EN-GB"&gt;Tema&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span lang="EN-GB"&gt;1.&lt;span style="font-style: italic;"&gt; &lt;/span&gt;&lt;/span&gt;Revisão Clássica&lt;br /&gt;&lt;b&gt;Hirsutismo&lt;/b&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span lang="EN-GB"&gt;2. &lt;/span&gt;&lt;span&gt;Panfleto&lt;/span&gt;&lt;span style="font-style: italic;"&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Varizes e insuficiência venosa&lt;/span&gt;&lt;/span&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;span style="font-weight: bold;"&gt;&lt;br /&gt;&lt;/span&gt;Ana Margarida Cruz e Alexandra Pina, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span style="font-style: italic;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;3. Caso clínico - poster&lt;br /&gt;&lt;b&gt;&lt;span lang="EN-GB"&gt;Tiroidite subclínica&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Alexandra Pina, Ana Margarida Cruz, USF Horizonte &lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;4. Panfleto&lt;b&gt;&lt;span lang="EN-GB"&gt;&lt;br /&gt;"Dormir sem contar ovelhas" - higiene do sono &lt;/span&gt;&lt;/b&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Joana Cabrita, Ana Margarida Cruz, USF Horizonte&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CUsers%5CClara%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 415 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0cm; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman";} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:10.0pt; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt;} @page WordSection1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.WordSection1 	{page:WordSection1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin:0cm; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style="line-height: 150%;font-family:&amp;quot;;font-size:10pt;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6272069848490173575?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6272069848490173575/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/04/educacao-medica-continua-2010.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6272069848490173575'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6272069848490173575'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/04/educacao-medica-continua-2010.html' title='Educação Médica Contínua 2010'/><author><name>Clara Pinto Ferreira</name><uri>http://www.blogger.com/profile/15131505695620815048</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_84hiOEfnTh8/SxAU115XWZI/AAAAAAAAAAM/E00thOGyrTw/S220/Caves+Taylor%27s+(4).JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4087030012383475444</id><published>2010-03-23T19:32:00.005Z</published><updated>2010-05-15T09:05:19.455+01:00</updated><title type='text'>Rotarix - suspensão temporária</title><content type='html'>&lt;span class="Apple-style-span"  style="font-family:arial;"&gt;AFood and Drugs Administration (FDA) anunciou ontem uma recomendação para suspensão temporária da vacina Rotarix, devido à descoberta presença de DNA um vírus alheio à vacina.&lt;br /&gt;&lt;br /&gt;Apesar de aparentemente a presença deste DNA ser inofensiva, a FDA recomenda a suspensão desta vacina enquanto estuda a situação.&lt;br /&gt; Para obter mais &lt;a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm205640.htm"&gt;informações&lt;/a&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4087030012383475444?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4087030012383475444/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/03/rotarix-suspensao-temporaria.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4087030012383475444'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4087030012383475444'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/03/rotarix-suspensao-temporaria.html' title='Rotarix - suspensão temporária'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3707824427060348364</id><published>2010-03-07T02:07:00.005Z</published><updated>2010-05-15T09:10:24.562+01:00</updated><title type='text'>Exame neurológico do recém-nascido</title><content type='html'>&lt;span class="Apple-style-span" style="WHITE-SPACE: pre;font-family:Arial, Helvetica, sans-serif;font-size:10;"  &gt;&lt;object height="385" width="480"&gt;&lt;param name="movie" value="http://www.youtube.com/v/XV_sI8odL3w&amp;amp;hl=en_US&amp;amp;fs=1&amp;amp;rel=0"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowscriptaccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/XV_sI8odL3w&amp;amp;hl=en_US&amp;amp;fs=1&amp;amp;rel=0" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="480" height="385"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify" align="left"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;Este vídeo foi gentilmente cedido pela Dra. Fátima Pinto e Dra. Ana Monteiro, que em conjunto com a Dra. Isabel Ruivo construíram o blogue &lt;a href="http://desenvolvimento-infantil.blogspot.com/"&gt;http://desenvolvimento-infantil.blogspot.com/&lt;/a&gt;, útil para profissionais de saúde, como nós, que lidam com crianças, e para pais, pelos conselhos dados!&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3707824427060348364?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3707824427060348364/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/03/exame-neurologico-do-recem-nascido.html#comment-form' title='2 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3707824427060348364'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3707824427060348364'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/03/exame-neurologico-do-recem-nascido.html' title='Exame neurológico do recém-nascido'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4414501260286224733</id><published>2010-02-22T18:05:00.008Z</published><updated>2010-02-22T18:29:28.799Z</updated><category scheme='http://www.blogger.com/atom/ns#' term='asma'/><category scheme='http://www.blogger.com/atom/ns#' term='LABA'/><title type='text'>FDA anunciou recomendações de segurança dos LABA (long acting beta agonists)</title><content type='html'>Em Fevereiro deste ano, a &lt;a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm200931.htm"&gt;FDA anuncia que os LABA&lt;/a&gt; não devem ser usados isoladamente no tratamento da asma na criança ou adulto. Após análise de vários estudos, provou-se que há um aumento de risco de agravamento dos sintomas com esta terapêutica isolada.&lt;div&gt;Assim, segundo a FDA e apenas para o tratamento da asma, os LABA:&lt;/div&gt;&lt;div&gt;- estão contraindicados na ausência de medicação de controlo, como os corticóides inalados. Deverão ser apenas utilizados em combinação com terapêutica de controlo;&lt;/div&gt;&lt;div&gt;- o uso a longo prazo apenas está indicado em doentes com asma que não apresentam um controlo adequado com terapêutica de controlo;&lt;/div&gt;&lt;div&gt;- deverão ser utilizados por um período mais breve possível, e descontinuados assim que se obtenha o controlo sintomático. &lt;/div&gt;&lt;div&gt;- nas crianças e adolescente que necessitem que seja acrescido um LABA ao corticóide inalado, deverão usar a terapêutica combinada num único dispositivo de forma a melhorar a adesão terapêutica.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4414501260286224733?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4414501260286224733/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/02/fda-anunciou-recomendacoes-de-seguranca.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4414501260286224733'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4414501260286224733'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2010/02/fda-anunciou-recomendacoes-de-seguranca.html' title='FDA anunciou recomendações de segurança dos LABA (long acting beta agonists)'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2457946933623041571</id><published>2009-11-29T18:26:00.002Z</published><updated>2009-11-29T23:10:22.123Z</updated><title type='text'>Novas recomendações Americanas para o rastreio do cancro do colo do útero</title><content type='html'>Estas novas recomendações (&lt;em&gt;Guidelines from the American College of Obstetricians and Gynecologists, 2009&lt;/em&gt;), apresentadas num &lt;a href="http://content.nejm.org/cgi/reprint/NEJMp0911380v1.pdf"&gt;&lt;strong&gt;artigo do NEJM&lt;/strong&gt;&lt;/a&gt; contêm três alterações principais.&lt;br /&gt;A primeira, diz respeito à idade do rastreio por Papanicolaou que se recomenda que seja iniciado aos 21 anos e que seja evitado antes disso.&lt;br /&gt;A segunda, diz respeito aos intervalos de rastreio que, segundo as recomendações, deverão ser de 2 em 2 anos dos 21 aos 29 anos, depois de 3 em 3 (nas mulheres que tenham tido 3 citologias consecutivas negativas.&lt;br /&gt;A terceira, refere-se à idade em que o rastreio deve terminar. As novas guidelines indicam que é razoável interromper o rastreio nas mulheres dos 65 aos 70 anos que tenham tido 3 ou mais citologias consecutivas sem alterações nos últimos 10 anos.&lt;br /&gt;&lt;br /&gt;As principais alterações nas recomendações podem ser lidas no &lt;a href="http://content.nejm.org/cgi/powerpoint/NEJMp0911380v1/T1"&gt;quadro resumo.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Sawaya GF. Cervical-Cancer Screening — New Guidelines and the Balance between Benefits and Harms. N Engl J Med; 10.1056/NEJMp0911380 &lt;/em&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2457946933623041571?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2457946933623041571/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/novas-recomendacoes-americanas-para-o.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2457946933623041571'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2457946933623041571'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/novas-recomendacoes-americanas-para-o.html' title='Novas recomendações Americanas para o rastreio do cancro do colo do útero'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5269621611992639773</id><published>2009-11-29T12:27:00.000Z</published><updated>2009-11-29T12:28:03.033Z</updated><title type='text'>Número de doses da vacina Pandemrix® - Actualização</title><content type='html'>A Agência Europeia do Medicamento (EMEA) e o INFARMED informaram que uma dose da vacina Pandemrix® pode ser suficiente para a protecção contra a infecção pelo vírus da gripe pandémica (H1N1)2009, à excepção das crianças até aos 10 anos e de doentes imunocomprometidos.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.dgs.pt/upload/membro.id/ficheiros/i012146.pdf"&gt;Circular Normativa nº 19/DSPCD de 23/11/2009&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5269621611992639773?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5269621611992639773/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/numero-de-doses-da-vacina-pandemrix.html#comment-form' title='1 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5269621611992639773'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5269621611992639773'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/numero-de-doses-da-vacina-pandemrix.html' title='Número de doses da vacina Pandemrix® - Actualização'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2889881975030340570</id><published>2009-11-28T10:42:00.000Z</published><updated>2009-11-28T10:43:34.536Z</updated><title type='text'>Sobre a Mamografia – Mais acordo do que desacordo</title><content type='html'>Existe consenso que o rastreio por mamografia leva a uma redução na mortalidade por cancro da mama nas mulheres entre os 40 e os 74 anos, apesar de não haver consenso sobre a data de início.&lt;br /&gt;A mamografia, contudo, continua a ser um teste bastante imperfeito, apesar de ser o melhor instrumento de rastreio disponível. São necessários testes mais precisos e custo-efectivos para diminuir o impacto do cancro da mama na comunidade.&lt;br /&gt;Pode continuar a haver debates sobre a idade óptima do início do rastreio, mas é certo que, num futuro próximo, os avanços técnicos farão desvanecer este debate&lt;br /&gt;&lt;br /&gt;&lt;a href="http://content.nejm.org/cgi/reprint/NEJMp0911288v1.pdf"&gt;Partridge AH, Winer EP. On Mammography — More Agreement Than Disagreement&lt;/a&gt;&lt;a href="http://content.nejm.org/cgi/reprint/NEJMp0911288v1.pdf"&gt;N Engl J Med. 2009 Nov 25. [Epub ahead of print]&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2889881975030340570?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2889881975030340570/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/sobre-mamografia-mais-acordo-do-que.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2889881975030340570'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2889881975030340570'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/sobre-mamografia-mais-acordo-do-que.html' title='Sobre a Mamografia – Mais acordo do que desacordo'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2068773655824134333</id><published>2009-11-13T20:04:00.004Z</published><updated>2009-11-14T10:46:26.393Z</updated><title type='text'>Factores de risco cardiovascular atípicos - recomendação USPSTF</title><content type='html'>A USPSTF publicou uma recomendação acerca do uso de factores de risco atípicos (PCR de alta sensibilidade, indice tornozelo-braço, glicemia em jejum, doença periodontal, espessamento da intima carotídea, score da calcificação das artérias coronárias, homocisteína e lipoproteina(a)) no cálculo do risco cardiovascular em adultos assintomáticos e sem antecedentes de doença CV, concluindo que a evidência disponível ainda é insuficiente para calcular os riscos benefícios da utilização destes EAD rotineiramente, para prevenir eventos CV. &lt;div&gt;Disponível em: &lt;a href="http://www.annals.org/content/151/7/474.full"&gt;http://www.annals.org/content/151/7/474.full&lt;/a&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2068773655824134333?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2068773655824134333/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/factores-de-risco-cardiovascular.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2068773655824134333'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2068773655824134333'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/11/factores-de-risco-cardiovascular.html' title='Factores de risco cardiovascular atípicos - recomendação USPSTF'/><author><name>Joana Cabrita</name><uri>http://www.blogger.com/profile/08232702710710086350</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4695203140998721988</id><published>2009-10-30T21:14:00.005Z</published><updated>2009-11-13T13:53:30.559Z</updated><title type='text'>Second Virtual Congress</title><content type='html'>No conforto do lar ou entre o trabalho do dia-a-dia é possível acompanhar o&lt;span class="Apple-style-span" style="FONT-STYLE: italic"&gt; &lt;a href="http://www.virtualcongressgpfm.com/"&gt;Second Virtual Congress &lt;/a&gt;.&lt;/span&gt; O tema principal é o &lt;span class="Apple-style-span" style="FONT-STYLE: italic"&gt;Empowerment - Towards Operational Knowledge.&lt;/span&gt; &lt;div&gt;Chamo a atenção para algumas &lt;span class="Apple-style-span" style="FONT-STYLE: italic"&gt;Keynotes &lt;/span&gt;disponíveis (duas do Dr. Jaime) e para a quantidade impressionante de trabalhos de várias nacionalidades organizados em 7 auditórios sob as diferentes temáticas. &lt;/div&gt;&lt;div&gt;Além disto, é gratuito, interactivo e ecológico! (não exige deslocações nem gastos adicionais)&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4695203140998721988?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4695203140998721988/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/no-conforto-do-lar-ou-entre-o-trabalho.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4695203140998721988'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4695203140998721988'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/no-conforto-do-lar-ou-entre-o-trabalho.html' title='Second Virtual Congress'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7969633417310331887</id><published>2009-10-25T11:35:00.000Z</published><updated>2009-10-25T11:37:48.121Z</updated><title type='text'>Plano de Desempenho de Agrupamentos de Centros de Saúde em Discussão</title><content type='html'>Encontra-se em discussão pública a proposta de &lt;a href="http://www.portaldasaude.pt/NR/rdonlyres/B8D37DC6-184F-4255-A2B3-0EB7474EF4CB/0/PDACES_DiscussaoPublica_14Out009.pdf"&gt;Plano de Desempenho para os Agrupamentos de Centros de Saúde&lt;/a&gt; (ACES).&lt;br /&gt;&lt;br /&gt;Esta proposta foi preparada pelo Grupo de Trabalho para a Contratualização com os Cuidados de Saúde e contou com os contributos de diferentes entidades do Ministério da Saúde, nomeadamente o Alto Comissariado da Saúde e a Direcção-Geral da Saúde, entre outras.&lt;br /&gt;&lt;br /&gt;Os interessados podem enviar os comentários e sugestões ao actual documento para o e-mail &lt;a href="mailto:uofc@acss.min-saude.pt"&gt;uofc@acss.min-saude.pt&lt;/a&gt; .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7969633417310331887?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7969633417310331887/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/plano-de-desempenho-de-agrupamentos-de.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7969633417310331887'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7969633417310331887'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/plano-de-desempenho-de-agrupamentos-de.html' title='Plano de Desempenho de Agrupamentos de Centros de Saúde em Discussão'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6179319633979863342</id><published>2009-10-17T19:15:00.001+01:00</published><updated>2009-10-17T19:48:35.796+01:00</updated><title type='text'>The GRADE System for Rating Clinical Guidelines</title><content type='html'>O autor apresenta uma crítica ao sistema para classificação das Normas de Orientação Clínica (NOC), &lt;a href="http://www.bmj.com/cgi/reprint/328/7454/1490.pdf"&gt;&lt;strong&gt;&lt;em&gt;GRADE&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;, já adoptado por muitas revistas científicas de grande reputação.&lt;br /&gt;&lt;br /&gt;Kavanagh BP, 2009 &lt;a href="http://www.plosmedicine.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.1000094&amp;amp;representation=PDF"&gt;&lt;strong&gt;&lt;em&gt;The GRADE System for Rating Clinical Guidelines&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;. PLoS Med 6(9): e1000094. doi:10.1371/journal.pmed.1000094.&lt;br /&gt;&lt;br /&gt;Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, et al. (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6179319633979863342?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6179319633979863342/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/grade-system-for-rating-clinical.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6179319633979863342'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6179319633979863342'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/grade-system-for-rating-clinical.html' title='The GRADE System for Rating Clinical Guidelines'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2297053109891033721</id><published>2009-10-17T18:48:00.001+01:00</published><updated>2009-10-17T19:17:06.301+01:00</updated><title type='text'>Agency for Toxic Substances and Disease Registry (ATSDR)</title><content type='html'>A &lt;a href="http://www.atsdr.cdc.gov/"&gt;&lt;em&gt;&lt;strong&gt;Agency for Toxic Substances and Disease Registry&lt;/strong&gt;&lt;/em&gt;&lt;/a&gt; (ATSDR), com sede em Atlanta, Georgia, EUA, é uma agência pública federal do &lt;em&gt;U.S. Department of Health and Human Services&lt;/em&gt;. A ATSDR presta um serviço público usando os melhores conhecimentos científicos, desencadeando acções de saúde pública e fornecendo informação de confiança para a prevenção da exposição nociva a doenças relacionadas com substâncias tóxicas.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2297053109891033721?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2297053109891033721/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/agency-for-toxic-substances-and-disease.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2297053109891033721'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2297053109891033721'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/agency-for-toxic-substances-and-disease.html' title='Agency for Toxic Substances and Disease Registry (ATSDR)'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-171955551296023920</id><published>2009-10-17T12:23:00.002+01:00</published><updated>2009-10-17T19:17:17.322+01:00</updated><title type='text'>Indicadores e Metas do Plano Nacional de Saúde 2011-2015 em Consulta</title><content type='html'>No âmbito do processo de construção do Plano Nacional de Saúde (PNS) 2011-2015, o Alto Comissariado da Saúde (ACS) disponibiliza para consulta e download no &lt;a href="http://www.acs.min-saude.pt/pns/pt/"&gt;seu site&lt;/a&gt; o &lt;a title="Link para Caderno de Encargos" href="http://www.acs.min-saude.pt/wp-content/uploads/2009/10/caderno-de-encargos-pns-2011-15-2009-10-13.pdf" target="_blank"&gt;caderno de encargos&lt;/a&gt; que define os princípios, objectivos, estrutura, funções, processos, metas e resultados esperados da construção do PNS.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-171955551296023920?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/171955551296023920/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/o-plano-nacional-da-saude-2004-2010.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/171955551296023920'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/171955551296023920'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/o-plano-nacional-da-saude-2004-2010.html' title='Indicadores e Metas do Plano Nacional de Saúde 2011-2015 em Consulta'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-9203106944959207182</id><published>2009-10-10T10:48:00.000+01:00</published><updated>2009-10-10T10:49:24.583+01:00</updated><title type='text'>Wolfram|Alpha computational knowledge engine</title><content type='html'>&lt;p&gt;Recomenda-se absolutamente uma visita ao site do &lt;a href="http://www97.wolframalpha.com/"&gt;WolframAlpha&lt;/a&gt;. Trata-se de um projecto ambicioso que permite a qualquer pessoa o acesso sistemático a uma enorme quantidade de dados que são processados de forma imediata cruzando informação com origens muito variadas.&lt;br /&gt;&lt;/p&gt;&lt;p&gt;Vale a pena seguir o &lt;a href="http://www97.wolframalpha.com/screencast/introducingwolframalpha.html"&gt;tutorial&lt;/a&gt; para ter uma noção do que se pode obter do site e depois experimentar pesquisar o que lhe puder ser útil ou simplesmente interessante. &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-9203106944959207182?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/9203106944959207182/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/wolframalpha-computational-knowledge.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9203106944959207182'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9203106944959207182'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/10/wolframalpha-computational-knowledge.html' title='Wolfram|Alpha computational knowledge engine'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1899039835514906582</id><published>2009-09-20T12:56:00.002+01:00</published><updated>2009-09-20T13:15:51.063+01:00</updated><title type='text'>Antropologia na prática clínica</title><content type='html'>A competência cultural entrou na moda entre os clínicos e investigadores e, no entanto, ninguém consegue definir o termo de forma suficientemente precisa para o operacionalizar em termos de formação clínica e de boas práticas. É claro que a cultura é importante na clínica e os factores culturais são cruciais para o diagnóstico, tratamento e cuidados de saúde.&lt;br /&gt;Neste importante artigo, &lt;em&gt;&lt;strong&gt;Arthur Kleinman &lt;/strong&gt;&lt;/em&gt;e &lt;strong&gt;&lt;em&gt;Peter Benson&lt;/em&gt;&lt;/strong&gt; introduzem o conceito de competência cultural e concluem que o conceito é algo mais do que uma simples competência; é, de facto uma afinidade electiva com o doente. Esta orientação deve fazer parte do próprio médico e as competências interpessoais devem tornar-se uma parte importante dos recursos clínicos do médico.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Kleinman A, Benson P. &lt;/em&gt;&lt;a href="http://www.plosmedicine.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.0030294&amp;amp;representation=PDF"&gt;&lt;em&gt;Anthropology in the clinic: The problem of cultural competency and how to fi x it&lt;/em&gt;&lt;/a&gt;&lt;em&gt;. PLoS Med 2006 3(10): e294. DOI: 10.1371/journal.pmed.0030294&lt;/em&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1899039835514906582?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1899039835514906582/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/antropologia-na-pratica-clinica.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1899039835514906582'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1899039835514906582'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/antropologia-na-pratica-clinica.html' title='Antropologia na prática clínica'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5765713236973292341</id><published>2009-09-20T11:13:00.001+01:00</published><updated>2009-09-20T11:15:21.088+01:00</updated><title type='text'>Barry's colonoscopy journal</title><content type='html'>O jornalista Dave Barry, galardoado com o prémio Pulitzer, é um humorista e colunista do Miami Herald.&lt;br /&gt;Neste artigo hilariante do Blogue &lt;strong&gt;&lt;em&gt;Medical Hu&lt;/em&gt;manities&lt;/strong&gt;, fala-nos da sua experiência ao submeter-se à realização de uma colonoscopia. A não perder.&lt;br /&gt;&lt;a href="http://medhum.blogspot.com/2009/09/barrys-colonoscopy-journal.html"&gt;&lt;em&gt;Barry's colonoscopy journal&lt;/em&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5765713236973292341?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5765713236973292341/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/barrys-colonoscopy-journal.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5765713236973292341'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5765713236973292341'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/barrys-colonoscopy-journal.html' title='Barry&apos;s colonoscopy journal'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5931377417756333289</id><published>2009-09-20T11:06:00.002+01:00</published><updated>2009-09-20T11:14:54.712+01:00</updated><title type='text'>Social Medicine in the 21st Century</title><content type='html'>Recomenda-se a leitura desta série de artigos em "&lt;em&gt;Open Access&lt;/em&gt;" no &lt;strong&gt;&lt;em&gt;PLoS Medicine&lt;/em&gt;&lt;/strong&gt; com o título de &lt;a href="http://collections.plos.org/plosmedicine/socialmedicine-2006.php"&gt;&lt;em&gt;A Collection of Articles on Social Medicine in the 21st Century&lt;/em&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5931377417756333289?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5931377417756333289/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/social-medicine-in-21st-century.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5931377417756333289'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5931377417756333289'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/09/social-medicine-in-21st-century.html' title='Social Medicine in the 21st Century'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6207208509433590208</id><published>2009-08-30T08:47:00.001+01:00</published><updated>2009-08-30T08:49:30.434+01:00</updated><title type='text'>Trick and treat - andaremos todos a comer mal?</title><content type='html'>O livro &lt;a href="http://www.amazon.com/Trick-Treat-healthy-eating-making/dp/1950140229"&gt;&lt;em&gt;Trick And Treat&lt;/em&gt;&lt;/a&gt;&lt;em&gt; - how 'healthy eating' is making us ill&lt;/em&gt;, da autoria do nutricionista britânico &lt;strong&gt;&lt;em&gt;Barry Groves&lt;/em&gt;&lt;/strong&gt;, contém vários capítulos com explicações sobre a forma incorrecta como temos sido orientados para determinados tipos de alimentação dita saudável; as afirmações do autor, bastante polémicas, são fundamentadas com recurso a extensa bibliografia e completadas por um &lt;a href="http://www.second-opinions.co.uk/index.html"&gt;site&lt;/a&gt; e por um &lt;a href="http://www.barrygroves.blogspot.com/"&gt;blog&lt;/a&gt; cuja leitura se sugere.&lt;br /&gt;&lt;br /&gt;Será que teremos que rever todas as nossas afirmações sobre alimentação? Recomenda-se a leitura do livro e a consulta de outros contributos acessíveis na net. Depois, teremos que debater o assunto e tirar as nossas conclusões.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6207208509433590208?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6207208509433590208/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/trick-and-treat-andaremos-todos-comer.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6207208509433590208'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6207208509433590208'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/trick-and-treat-andaremos-todos-comer.html' title='Trick and treat - andaremos todos a comer mal?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2214724084851880793</id><published>2009-08-24T22:16:00.001+01:00</published><updated>2009-08-24T22:18:14.526+01:00</updated><title type='text'>Disease Mongering – a Promoção da Doença</title><content type='html'>O termo ”disease mongering” foi criado para designar as actividades da indústria farmacêutica ou de tecnologias de saúde, dos grupos de pressão (médicos e outros) e dos media dirigidas ao grande público ou aos profissionais de saúde com o objectivo de promover a venda de produtos ou serviços.&lt;br /&gt;O assunto já foi oportunamente tratado nas páginas da RPCG por Miguel Melo (&lt;a href="http://www.apmcg.pt/Download.aspx?file=+H9KsPBBThmkjxXxYr2tnXdAGpp+iBF0xwcv8uDrTfUPBD7l5GS042Atn4zwfC8lkgxZCKdS2nIguAeCZ7M/K7XWnJPU84MpyGhohLMPl5M7eFq6N2Xksx16QQoJGwAs&amp;amp;name=A%20Promoção%20da%20Doença"&gt;ler em&lt;/a&gt; e &lt;a href="http://www.apmcg.pt/Download.aspx?file=+H9KsPBBThmkjxXxYr2tnXdAGpp+iBF0xwcv8uDrTfUPBD7l5GS042Atn4zwfC8lkgxZCKdS2nIguAeCZ7M/KwLkRFUBQiUfMwHY97DTi9PMHy/mcfpyxBSfNyCLNKAJ&amp;amp;name=A%20prevenção%20quaternária%20contra..."&gt;em&lt;/a&gt;). Nesta &lt;a href="http://collections.plos.org/plosmedicine/pdf/plme-03-04-diseasemongering.pdf"&gt;excelente colectânea&lt;/a&gt; da Public Library of Science é possível ler uma série de artigos que cobre um largo espectro do tema. Em breve será apresentado aos leitores do Para Além do Horizonte uma perspectiva mais alargada deste assunto.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2214724084851880793?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2214724084851880793/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/disease-mongering-promocao-da-doenca.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2214724084851880793'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2214724084851880793'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/disease-mongering-promocao-da-doenca.html' title='Disease Mongering – a Promoção da Doença'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4390743867320366428</id><published>2009-08-24T21:54:00.001+01:00</published><updated>2009-08-24T21:56:10.510+01:00</updated><title type='text'>2008 British Guideline on the Management of Asthma - updated June 2009</title><content type='html'>The new 2008 guideline (revised June 2009) contains a completely rewritten section on diagnosis for both adults and children; a section on special situations which includes occupational asthma, asthma in pregnancy and the new topic of difficult asthma; updated sections on pharmacological and non-pharmacological management; and amalgamated sections on patient education and compliance, and on organisation of care and audit.&lt;br /&gt;To download the full guideline (June 2009 update) click &lt;a href="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/Guidelines/Asthma_fullguideline_2009.pdf" target="_blank"&gt;here&lt;/a&gt;&lt;br /&gt;To download the quick reference guide (June 2009 update) click &lt;a href="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/Guidelines/qrg_update.pdf" target="_blank"&gt;here&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4390743867320366428?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4390743867320366428/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/2008-british-guideline-on-management-of.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4390743867320366428'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4390743867320366428'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/2008-british-guideline-on-management-of.html' title='2008 British Guideline on the Management of Asthma - updated June 2009'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5562850448512258950</id><published>2009-08-07T10:31:00.005+01:00</published><updated>2009-08-13T19:16:50.376+01:00</updated><title type='text'>A Rational Approach to the Initiation of Insulin Therapy in Older Adults</title><content type='html'>&lt;a href="http://1.bp.blogspot.com/_NZEcGSl-WDU/Snv2AhOFMoI/AAAAAAAAATo/w8r5Wnknsq8/s1600-h/705672-fig2.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 320px; DISPLAY: block; HEIGHT: 213px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5367153869719941762" border="0" alt="" src="http://1.bp.blogspot.com/_NZEcGSl-WDU/Snv2AhOFMoI/AAAAAAAAATo/w8r5Wnknsq8/s320/705672-fig2.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;From &lt;a href="http://www.medscape.com/viewpublication/1228"&gt;Geriatrics &amp;amp; Aging&lt;/a&gt;, Mae Sheikh-Ali, MD; Joe M. Chehade, MD&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.medscape.com/viewarticle/705672"&gt;Ver em:&lt;/a&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5562850448512258950?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5562850448512258950/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/rational-approach-to-initiation-of.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5562850448512258950'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5562850448512258950'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/rational-approach-to-initiation-of.html' title='A Rational Approach to the Initiation of Insulin Therapy in Older Adults'/><author><name>XPina</name><uri>http://www.blogger.com/profile/02679244254910142190</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_NZEcGSl-WDU/Snv2AhOFMoI/AAAAAAAAATo/w8r5Wnknsq8/s72-c/705672-fig2.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7991732334886225256</id><published>2009-08-02T07:31:00.000+01:00</published><updated>2009-08-02T07:32:12.231+01:00</updated><title type='text'>Consulta Pública sobre Saúde aponta Desigualdades como Problema Grave na Europa</title><content type='html'>Foi publicado o &lt;a title="Link para Relatório da Comissão Europeia" href="http://www.portaldasaude.pt/NR/rdonlyres/E696BF83-F4E8-4152-A1F1-9F81AAF96D53/0/cons_report_en.pdf" target="_blank"&gt;relatório das respostas recebidas na consulta pública&lt;/a&gt; sobre desigualdades em matéria de saúde, lançada pela Comissão Europeia dentro e entre os Estados-Membros. A grande maioria dos participantes reconhece as desigualdades na Saúde como um grave problema e com tendência para aumentar.&lt;br /&gt;&lt;br /&gt;Em &lt;a title="Link para Comunicado do Ministério da Saúde" href="http://www.portaldasaude.pt/portal/conteudos/a+saude+em+portugal/noticias/saude+na+ue.htm" target="_blank"&gt;comunicado&lt;/a&gt;, o Ministério da Saúde revela que as respostas da consulta pública sobre a forma como a União Europeia (UE) pode contribuir para reduzir as desigualdades no domínio da Saúde, dentro e entre os Estados-Membros, já foram publicadas. Ao documento, composto por 148 questões, lançado para consulta pública em Fevereiro, foram dadas 125 respostas, entre as quais 13 de Estados-Membros e 52 de organizações de âmbito comunitário da UE.&lt;br /&gt;&lt;br /&gt;O relatório revela que a grande maioria dos participantes reconhece as desigualdades de Saúde dentro e entre os Estados-Membros como um grave problema e acreditam que a actual crise económica deverá, por exemplo, levar ao aumento de grupos com doença do foro psicológico.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.portaldocidadao.pt/PORTAL/pt/noticias/07_2009/NEWS_consulta+publica+sobre+saude+aponta+desigualdades+como+problema+grave+na+europa.htm"&gt;Ler resumo em:&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7991732334886225256?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7991732334886225256/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/consulta-publica-sobre-saude-aponta.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7991732334886225256'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7991732334886225256'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/consulta-publica-sobre-saude-aponta.html' title='Consulta Pública sobre Saúde aponta Desigualdades como Problema Grave na Europa'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7523091862497435520</id><published>2009-08-01T07:33:00.001+01:00</published><updated>2009-08-01T07:33:51.530+01:00</updated><title type='text'>The Burden of Health Care Costs for Working Families — Implications for Reform</title><content type='html'>Os Conselheiros Económicos do Presidente Obama apresentaram em 2 de Junho de 2009 um relatório em que avaliam as implicações económicas da reforma de cuidados de saúde e salientam a importância da contenção de custos na sustentabilidade a longo termo de qualquer reforma.&lt;br /&gt;&lt;br /&gt;Polsky D, Grande D. &lt;a href="http://content.nejm.org/cgi/reprint/361/5/437.pdf"&gt;The burden of health care costs for working families--implications for reform&lt;/a&gt;. N Engl J Med. 2009 Jul 30;361(5):437-9.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7523091862497435520?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7523091862497435520/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/burden-of-health-care-costs-for-working.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7523091862497435520'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7523091862497435520'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/burden-of-health-care-costs-for-working.html' title='The Burden of Health Care Costs for Working Families — Implications for Reform'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-9117473596714915965</id><published>2009-08-01T07:17:00.002+01:00</published><updated>2009-08-01T07:19:29.820+01:00</updated><title type='text'>CDC Issues H1N1 Vaccination Recommendations</title><content type='html'>&lt;p&gt;New H1N1 influenza vaccine recommendations from the Centers for Disease Control and Prevention (CDC) suggest priority distribution among 5 groups. &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Pregnant women, &lt;/li&gt;&lt;li&gt;Household contacts of children who are younger than 6 months of age, &lt;/li&gt;&lt;li&gt;Healthcare workers and emergency medical services personnel, &lt;/li&gt;&lt;li&gt;Children and young people between the ages of 6 months and 24 years of age, and &lt;/li&gt;&lt;li&gt;Nonelderly adults with underlying risk conditions or medical conditions that increase their risk for complications from influenza. &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;a href="http://www.medscape.com/viewarticle/706775?src=mpnews&amp;amp;spon=34&amp;amp;uac=128980MJ"&gt;Ler em:&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-9117473596714915965?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/9117473596714915965/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/cdc-issues-h1n1-vaccination.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9117473596714915965'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/9117473596714915965'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/08/cdc-issues-h1n1-vaccination.html' title='CDC Issues H1N1 Vaccination Recommendations'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1220434307669865576</id><published>2009-07-25T23:08:00.001+01:00</published><updated>2009-07-25T23:10:14.572+01:00</updated><title type='text'>Tem ido à biblioteca?</title><content type='html'>A Biblioteca da ULSM.&lt;br /&gt;Por vezes esquecemo-nos que ela existe. Como está localizada no hospital e o acesso às subscrições online através dos computadores dos centros de saúde nem sempre é possível, nem nos lembramos de ir lá ver se é possível obter o artigo de que necessitamos. Talvez que, se fizermos mais uso da biblioteca, se interagirmos com os responsáveis e se solicitarmos as assinaturas das revistas de que necessitamos, ela se possa transformar num centro de documentação também ao serviço dos cuidados de saúde primários. E se &lt;a href="http://www.ulsm.pt/biblioteca/"&gt;experimentasse&lt;/a&gt;?&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1220434307669865576?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1220434307669865576/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/tem-ido-biblioteca.html#comment-form' title='3 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1220434307669865576'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1220434307669865576'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/tem-ido-biblioteca.html' title='Tem ido à biblioteca?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8508252726879420478</id><published>2009-07-25T18:51:00.000+01:00</published><updated>2009-07-25T18:53:44.551+01:00</updated><title type='text'>Why We Must Ration Health Care</title><content type='html'>Os custos do actual sistema de saúde estão-se a tornar extremamente elevados e começa a crescer na opinião pública a opinião sobre a necessidade de uma abordagem mais sistemática.&lt;br /&gt;Este interessante artigo do New York Times pode ser lido em &lt;a href="http://www.nytimes.com/2009/07/19/magazine/19healthcare-t.html?_r=2&amp;amp;pagewanted=1&amp;amp;th&amp;amp;emc=th"&gt;Ligação&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8508252726879420478?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8508252726879420478/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/why-we-must-ration-health-care.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8508252726879420478'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8508252726879420478'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/why-we-must-ration-health-care.html' title='Why We Must Ration Health Care'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6086098119470698830</id><published>2009-07-19T11:30:00.003+01:00</published><updated>2009-07-19T21:51:11.567+01:00</updated><title type='text'>Lansoprazole 15 mg Once Daily for 14 Days Is Effective for Treatment of Frequent Heartburn</title><content type='html'>&lt;div style="TEXT-ALIGN: justify"&gt;Tratamentos de 14 dias com Lansoprazol 15 mg , parecem eficazes em pessoas com sintomas frequentes de refluxo (sem DRGE). O alivio sintomático mantem-se por 24 horas sendo a medicação e a dosagem utilizada bem tolerada. &lt;/div&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.postgradmed.com/index.php?free=pgm_07_2009?article=2019&amp;amp;ex=2019"&gt;Ler em:&lt;/a&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6086098119470698830?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6086098119470698830/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/lansoprazole-15-mg-once-daily-for-14.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6086098119470698830'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6086098119470698830'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/lansoprazole-15-mg-once-daily-for-14.html' title='Lansoprazole 15 mg Once Daily for 14 Days Is Effective for Treatment of Frequent Heartburn'/><author><name>Luis F. Silva</name><uri>http://www.blogger.com/profile/11232420931228278738</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3330040042632529043</id><published>2009-07-19T11:20:00.006+01:00</published><updated>2009-07-19T21:50:31.295+01:00</updated><title type='text'>Prevention, Screening, and Management  of Osteoporosis: An Overview of the Current  Strategies</title><content type='html'>&lt;p style="MARGIN: 0px; FONT: 9px Times; TEXT-ALIGN: left"&gt;&lt;span class="Apple-style-span"  style="font-family:arial;"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;Osteoporosis is a major public health concern, resulting in increased fracture risk. Osteoporosis-related fractures impose a considerable economic burden on health care systems, and the disease has severe, debilitating consequences if left untreated. Measures for osteoporosis prevention should begin at childhood and include balanced nutrition, physical activity, and avoidance of risk factors such as smoking. In adulthood, early recognition of osteoporosis followed by timely and effective management can reduce fracture risk. However, the rates of screening and treatment for osteoporosis are low, even in patients who have sustained a fragility fracture. Comprehensive fracture risk assessment should be part of routine patient care. Nonpharmacologic strategies to improve or maintain bone health should always be implemented, but many patients also need pharmacologic intervention to achieve adequate fracture protection. Several pharmacologic therapies are currently available, and when choosing from the available options, clinicians should consider the efﬁ cacy and safety proﬁ les of each therapy as well as the individual patient’s needs and overall health. Ideally, therapy should satisfy multiple criteria: fracture protection across multiple skeletal sites; rapid onset of action to maximize the timing of fracture protection; and minimal side effects with proven long-term safety.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="MARGIN: 0px; FONT: 9px Times; TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"  style="font-family:arial, fantasy;"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="MARGIN: 0px; FONT: 8px Gill Sans"&gt;&lt;span class="Apple-style-span"  style="font-size:small;"&gt;&lt;a href="http://www.postgradmed.com/index.php?free=pgm_07_2009?article=2021&amp;amp;ex=2021#none"&gt;Disponível em:&lt;/a&gt; &lt;/span&gt;&lt;/p&gt;&lt;span class="Apple-style-span"   style="font-family:Helvetica, fantasy;font-size:100%;"&gt;&lt;span class="Apple-style-span"  style="font-size:12;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3330040042632529043?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3330040042632529043/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/prevention-screening-and-management-of.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3330040042632529043'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3330040042632529043'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/prevention-screening-and-management-of.html' title='Prevention, Screening, and Management  of Osteoporosis: An Overview of the Current  Strategies'/><author><name>Luis F. Silva</name><uri>http://www.blogger.com/profile/11232420931228278738</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3265001897602894770</id><published>2009-07-18T16:01:00.000+01:00</published><updated>2009-07-18T16:02:22.726+01:00</updated><title type='text'>Alimentação em Tempos de Gripe</title><content type='html'>Alimentação em Tempos de Gripe é um livro electrónico produzido pela Faculdade de Ciências da Nutrição e Alimentação da Universidade do Porto (FCNAUP) desenvolvido com o objectivo de disponibilizar à comunidade ferramentas para planear a sua alimentação de forma a fazer face a uma eventual "situação de mudança de rotinas sem alarmismos".&lt;br /&gt;&lt;br /&gt;&lt;a href="https://sigarra.up.pt/fcnaup/noticias_geral.noticias_cont?p_id=F1403294487/ebookISBN9789729684067.pdf"&gt;Ler em&lt;/a&gt;:&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3265001897602894770?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3265001897602894770/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/alimentacao-em-tempos-de-gripe.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3265001897602894770'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3265001897602894770'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/alimentacao-em-tempos-de-gripe.html' title='Alimentação em Tempos de Gripe'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1851306770269500034</id><published>2009-07-16T21:18:00.003+01:00</published><updated>2009-07-18T16:22:46.600+01:00</updated><title type='text'>WHO Says New Flu "Unstoppable," Calls for Vaccine</title><content type='html'>Ummm, onde isto já vai, aparentemente a OMS deu luz verde as farmacêuticas para a produção em maciça de vacinas, aparentemente os profissionais de saúde vão ser os primeiros, colegas preparem os seus deltoides, e o Governo vai preparar a carteira, parece-me que isto nos vai sair caro.... &lt;div&gt;&lt;a href="http://www.medscape.com/viewarticle/705939"&gt;Disponível em:&lt;/a&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1851306770269500034?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1851306770269500034/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/who-says-new-flu-unstoppable-calls-for.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1851306770269500034'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1851306770269500034'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/who-says-new-flu-unstoppable-calls-for.html' title='WHO Says New Flu &quot;Unstoppable,&quot; Calls for Vaccine'/><author><name>Luis F. Silva</name><uri>http://www.blogger.com/profile/11232420931228278738</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-976825497191322915</id><published>2009-07-16T21:09:00.003+01:00</published><updated>2009-07-18T16:23:19.871+01:00</updated><title type='text'>Telmisartan, Candesartan May Not Prevent Renal Disease or Microalbuminuria</title><content type='html'>Os resultados de dois estudos separados (TRANSCEND e DIRECT), parecem desfavoráveis no que diz respeito a prevenção da doença renal/microalbuminuria, interesante artigo de opinião. &lt;div&gt;&lt;a href="http://www.medscape.com/viewarticle/705969"&gt;Disponível em:&lt;/a&gt; &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-976825497191322915?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/976825497191322915/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/telmisartan-candesartan-may-not-prevent.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/976825497191322915'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/976825497191322915'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/telmisartan-candesartan-may-not-prevent.html' title='Telmisartan, Candesartan May Not Prevent Renal Disease or Microalbuminuria'/><author><name>Luis F. Silva</name><uri>http://www.blogger.com/profile/11232420931228278738</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6907259401705736148</id><published>2009-07-10T09:46:00.001+01:00</published><updated>2009-07-12T12:23:22.180+01:00</updated><title type='text'>Long-Term Use of Antidepressants For Depressive Disorders and the Risk of Diabetes Mellitus</title><content type='html'>Changes Clinical Practice: Patients receiving a moderate to high daily dose of antidepressants for greater than 12 months should be evaluated for impaired glucose tolerance/diabetes. The authors of this study have shown that the long-term use of antidepressants in at least moderate daily doses was associated with an increased risk of diabetes. This finding indicates that blood glucose levels should be checked periodically in patients on long-term antidepressant therapy. &lt;a href="http://www.f1000medicine.com/article/id/1161024"&gt;Disponível em:&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6907259401705736148?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6907259401705736148/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/long-term-use-of-antidepressants-for.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6907259401705736148'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6907259401705736148'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/long-term-use-of-antidepressants-for.html' title='Long-Term Use of Antidepressants For Depressive Disorders and the Risk of Diabetes Mellitus'/><author><name>Luis F. Silva</name><uri>http://www.blogger.com/profile/11232420931228278738</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2300206891523746932</id><published>2009-07-01T23:59:00.001+01:00</published><updated>2009-07-01T23:59:57.201+01:00</updated><title type='text'>Orientações Clínicas Ambulatórias em Idade Pediátrica</title><content type='html'>Orientações clínicas elaboradas por uma equipa de pediatras e médicos de família dos locais que integram a rede UPIP (Urgência Pediátrica Integrada do Porto).&lt;br /&gt;&lt;br /&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Planeamento%20Estrat%C3%A9gico/Rede%20de%20Urg%C3%AAncias/UPIP%20-%20Anexos/Orientacoes_Clinicas.pdf"&gt;Ler em&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2300206891523746932?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2300206891523746932/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/orientacoes-clinicas-ambulatorias-em.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2300206891523746932'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2300206891523746932'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/07/orientacoes-clinicas-ambulatorias-em.html' title='Orientações Clínicas Ambulatórias em Idade Pediátrica'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5753452230585131722</id><published>2009-06-28T12:54:00.001+01:00</published><updated>2009-06-28T12:54:58.259+01:00</updated><title type='text'>Número especial do Eurosurveillance sobre gravidez e doenças infecciosas</title><content type='html'>Um certo número de infecções víricas e bacterianas em mulheres grávidas podem ter consequências sérias para o nascituro provocando problemas mentais e físicos mais tarde. Este &lt;a href="http://www.eurosurveillance.org/images/dynamic/EE/V14N09/V14N09.pdf"&gt;número do Eurosurveillance&lt;/a&gt; é dedicado às doenças infecciosas e gravidez.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5753452230585131722?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5753452230585131722/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/numero-especial-do-eurosurveillance.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5753452230585131722'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5753452230585131722'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/numero-especial-do-eurosurveillance.html' title='Número especial do Eurosurveillance sobre gravidez e doenças infecciosas'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4466140839797265482</id><published>2009-06-28T08:21:00.002+01:00</published><updated>2009-07-18T16:30:30.744+01:00</updated><title type='text'>A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)V</title><content type='html'>Foram analisadas amostras de 79 indivíduos sintomáticos com uma história recente de viagem para países com transmissão confirmada de influenza A(H1N1)v (North America) para um espectro largo de agentes que possam causar infecções respiratórias agudas. Esta análise revelou que, para além de quatro casos de influenza A(H1N1)v, foram diagnosticados outros vírus respiratórios em quase 60% das amostras. A definição de caso suspeito por critérios clínicos e epidemiológicos tem uma baixa capacidade para distinguir entre influenza A(H1N1)v e outras infecções víricas.&lt;br /&gt;&lt;br /&gt;Follin P, Lindqvist A, Nyström K, Lindh M. A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. Euro Surveill. 2009;14(24):pii=19242.&lt;br /&gt;&lt;a href="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19242"&gt;Disponível em:&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4466140839797265482?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4466140839797265482/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/variety-of-respiratory-viruses-found-in.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4466140839797265482'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4466140839797265482'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/variety-of-respiratory-viruses-found-in.html' title='A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)V'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3606235931581542079</id><published>2009-06-27T19:44:00.000+01:00</published><updated>2009-06-27T19:46:34.493+01:00</updated><title type='text'>Evidence Based Medicine Guidelines</title><content type='html'>A APMCG disponibiliza no seu site acesso às &lt;strong&gt;&lt;em&gt;Evidence Based Medicine Guidelines&lt;/em&gt;&lt;/strong&gt;. São de origem finlandesa, disponíveis em inglês.&lt;br /&gt;Para a sua consulta, não é necessário qualquer requisito excepto o de ser médico, e o de fazer o respectivo registo no site da APMCG.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.apmcg.pt/PageGen.aspx?WMCM_PaginaId=33698&amp;amp;WMCM_PaginaProtegidaId=33686"&gt;Ver em&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3606235931581542079?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3606235931581542079/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/evidence-based-medicine-guidelines.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3606235931581542079'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3606235931581542079'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/evidence-based-medicine-guidelines.html' title='Evidence Based Medicine Guidelines'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6641418905034413994</id><published>2009-06-20T10:57:00.000+01:00</published><updated>2009-06-20T10:58:40.421+01:00</updated><title type='text'>Some surprises in update to European hypertension guidelines?</title><content type='html'>A &lt;em&gt;&lt;strong&gt;European Society of Hypertension&lt;/strong&gt;&lt;/em&gt; (ESH) anunciou durante o &lt;em&gt;European Meeting on Hypertension 2009&lt;/em&gt;  a publicação da actualização das &lt;em&gt;guidelines&lt;/em&gt; de 2007 que serão publicadas no número de Outubro de 2009 do &lt;em&gt;Journal of Hypertension&lt;/em&gt;.&lt;br /&gt;&lt;a href="http://www.theheart.org/article/979043.do"&gt;Ler em.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6641418905034413994?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6641418905034413994/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/some-surprises-in-update-to-european.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6641418905034413994'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6641418905034413994'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/some-surprises-in-update-to-european.html' title='Some surprises in update to European hypertension guidelines?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4652224875337085956</id><published>2009-06-18T23:07:00.001+01:00</published><updated>2009-06-18T23:09:50.885+01:00</updated><title type='text'>Homenagem a Cecil Helman</title><content type='html'>&lt;a href="http://www.cecilhelman.com/"&gt;Cecil Helman&lt;/a&gt; morreu no dia 16 de Junho.&lt;br /&gt;&lt;br /&gt;Um dos grandes vultos da medicina geral e familiar, Cecil Helman nasceu na África do Sul em 1944 e frequentou o curso de medicina na University of Cape Town Medical School. Saiu da África do Sul devido ao apartheid e estudou antropologia médica no University College London.&lt;br /&gt;&lt;br /&gt;Trabalhou como médico de família e foi professor na &lt;a href="http://www.brunel.ac.uk/about/acad/sss/depts/anthropology/anth_staff/cecilhelman"&gt;Brunel University&lt;/a&gt;, West London e no Department of Primary Care &amp;amp; Population Sciences, Royal Free &amp;amp; University College Medical School (University College London). O seu livro &lt;a href="http://www.amazon.co.uk/gp/product/0340914505/ref=s9_simp_gw_s1_p14_t1?pf_rd_m=A3P5ROKL5A1OLE&amp;amp;pf_rd_s=center-1&amp;amp;pf_rd_r=1YNX3PQ98PXT075HQ63S&amp;amp;pf_rd_t=101&amp;amp;pf_rd_p=467198433&amp;amp;pf_rd_i=468294"&gt;Culture, Health and Illness&lt;/a&gt;, já com várias edições, é uma obra fundamental para a formação dos futuros médicos de família.&lt;br /&gt;&lt;br /&gt;Mostrou-se sempre interessado pelo bem-estar das pessoas e das comunidades e empenhado em perceber os seres humanos e as suas culturas. Como médico, professor e escritor, procurou sempre transmitir uma atitude de tolerância e compreensão pelas diferenças antropológicas entre os grupos étnicos e as culturas, preparando os médicos para melhor entenderem e interagirem com os seus doentes.&lt;br /&gt;&lt;br /&gt;Com a sua partida, ficámos mais pobres.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://medhum.blogspot.com/2009/06/tribute-to-dr-cecil-helman.html"&gt;Ler mais&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4652224875337085956?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4652224875337085956/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/homenagem-cecil-helman.html#comment-form' title='1 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4652224875337085956'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4652224875337085956'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/homenagem-cecil-helman.html' title='Homenagem a Cecil Helman'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-748968064717650504</id><published>2009-06-18T18:24:00.000+01:00</published><updated>2009-06-18T18:25:22.390+01:00</updated><title type='text'>OPSS - Relatório Primavera de 2009</title><content type='html'>O Observatório Português dos Sistemas de Saúde (OPSS) apresentou no dia 18 de Junho o &lt;a href="http://www.portaldasaude.pt/NR/rdonlyres/D863D907-370B-4A3E-9A21-1C94DBA77D33/0/RPrimavera2009OPSS.pdf"&gt;Relatório Primavera 2009&lt;/a&gt;.&lt;br /&gt;O relatório foi elaborado sob o tema "10 Anos de Observatório Português de Sistemas de Saúde, o que mudou?".&lt;br /&gt;&lt;br /&gt;Temas abordados:&lt;br /&gt;&lt;ul&gt;&lt;li&gt;Listas de espera cirúrgicas; &lt;/li&gt;&lt;li&gt;Reforma nos cuidados de saúde primários; &lt;/li&gt;&lt;li&gt;Empresarialização e política do medicamento.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;O Relatório Primavera de 2009 pretende reflectir e compreender o peso das críticas contínuas feitas pelo OPSS ao longo de 10 anos nas transformações operadas em Portugal pelos players na área da saúde.&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-748968064717650504?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/748968064717650504/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/opss-relatorio-primavera-de-2009.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/748968064717650504'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/748968064717650504'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/opss-relatorio-primavera-de-2009.html' title='OPSS - Relatório Primavera de 2009'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7387102452128424567</id><published>2009-06-13T08:22:00.001+01:00</published><updated>2009-06-13T08:22:58.202+01:00</updated><title type='text'>ADA 2009: Expert Committee Recommends Use of Hemoglobin A1C for Diagnosis of Diabetes</title><content type='html'>The American Diabetes Association (ADA), the International Diabetes Federation (IDF), and the European Association for the Study of Diabetes (EASD) have joined forces to recommend the use of the hemoglobin A1C assay for the diagnosis of diabetes.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.medscape.com/viewarticle/704021"&gt;Ler artigo&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7387102452128424567?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7387102452128424567/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/ada-2009-expert-committee-recommends.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7387102452128424567'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7387102452128424567'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/ada-2009-expert-committee-recommends.html' title='ADA 2009: Expert Committee Recommends Use of Hemoglobin A1C for Diagnosis of Diabetes'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7295941275410309820</id><published>2009-06-10T12:27:00.001+01:00</published><updated>2009-06-10T12:27:42.425+01:00</updated><title type='text'>Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis</title><content type='html'>Foi realizada uma pesquisa na MEDLINE, PsycINFO, Scopus e nas bases de dados Cochrane, até Agosto de 2008. Foram revistas as listas de referências dos artigos pertinentes, as meta-análises e as revisões acerca dos anti-depressivos no síndroma de fibromialgia (SFM).&lt;br /&gt;Conclusão: As medicações anti-depressivas estão associadas a melhoria na dor, depressão, fadiga, transtornos do sono e qualidade de vida relacionada com a saúde em pacientes com síndroma de fibromialgia.&lt;br /&gt;&lt;br /&gt;&lt;a href="https://www.rima.org/asp/medline/redirector.asp?uid=50013415&amp;amp;med=7062&amp;amp;tipo=VerArticulo&amp;amp;url=http://www.rima.org/web/medline_pdf/Treatment.pdf"&gt;Häuser W, Bernardy K, Uçeyler N e tal. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA: the Journal of the American Medical Association 2009; 301(2): 198-209.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7295941275410309820?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7295941275410309820/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/treatment-of-fibromyalgia-syndrome-with.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7295941275410309820'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7295941275410309820'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/treatment-of-fibromyalgia-syndrome-with.html' title='Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1824215872335170764</id><published>2009-06-10T11:55:00.000+01:00</published><updated>2009-06-10T11:57:27.322+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Rastreio'/><title type='text'>Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening</title><content type='html'>Os testes de rastreio múltiplos têm sido defendidos para a população em geral; contudo, médicos e doentes nem sempre estão bem informados sobre os riscos do rastreio, de um resultado falso-positvo e do risco acrescido de um procedimento diagnóstico. Os autores analisaram os resultados do &lt;em&gt;Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial&lt;/em&gt;, que englobou 68436 participantes. As conclusões são que, para uma pessoa submetida a um rastreio oncológico multimodal, o risco de um resultado falso-positivo é de cerca de 50% ou mais a partir do 14º teste.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.annfammed.org/cgi/reprint/7/3/212.pdf"&gt;Croswell et al. Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening. Ann Fam Med 2009;7:212-222. DOI: 10.1370/afm.942.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1824215872335170764?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1824215872335170764/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/cumulative-incidence-of-false-positive.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1824215872335170764'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1824215872335170764'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/cumulative-incidence-of-false-positive.html' title='Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2952687054094440109</id><published>2009-06-01T15:59:00.003+01:00</published><updated>2009-06-01T18:53:42.737+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='lombalgia'/><title type='text'>Dor lombar não específica</title><content type='html'>A lombalgia não específica é uma situação clínica muito comum nos cuidados de saúde primários. Tratando-se de um diagnóstico de exclusão que apresenta um impacto significativo na qualidade de vida do doente, exige uma abordagem terapêutica personalizada e adequada. Importa estar a par das várias possibilidades farmacológicas e não farmacológicas que poderão ser instituídas. Em Maio de 2009 foram publicadas pelo &lt;a href="http://www.nice.org.uk/guidance/CG88"&gt;National Institute for Health and Clinical Excellence (NICE)&lt;/a&gt; normas de orientação clínica sobre a lombalgia NE persistente (duração superior a 6 semanas).&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2952687054094440109?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2952687054094440109/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/dor-lombar-nao-especifica.html#comment-form' title='1 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2952687054094440109'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2952687054094440109'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/06/dor-lombar-nao-especifica.html' title='Dor lombar não específica'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-661833056052664810</id><published>2009-05-31T23:25:00.005+01:00</published><updated>2009-06-02T12:35:09.976+01:00</updated><title type='text'>Eficácia relativa de antidepressivos comuns- Estaremos a fazer as melhores opções?</title><content type='html'>Embora com edições menos frequentes, a &lt;strong&gt;Bandolier&lt;em&gt;- evidence based thinking about healthcare &lt;/em&gt;&lt;/strong&gt;continua a oferecer-nos periodicamente boas análises críticas da literatura, acompanhadas invariavelmente pelos assertivos comentários dos seus editores sobre os aspectos que interessam, de facto, em cada novo artigo ao clínico a exercer "&lt;em&gt;at the point of care", &lt;/em&gt;e sobre as falácias a cuidar na adopção imediata das conclusões fáceis de alguns estudos.&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;No número de Abril de 2009, são os antidepressivos da nova geração o tema de discussão. Partindo de um conjunto relativamente importante de estudos de pequena / média dimensão, os autores analisam os seus resultados com recurso a uma meta-análise, considerando na sua avaliação o desempenho obtido por cada substância em termos de efectividade e de tolerabilidade. O objectivo é procurar indícios de perfis de custo-benefício relativos a substâncias das quais com muita frequência não dispomos de análises comparativas entre si.&lt;br /&gt;Vale sem dúvida a pena ler.&lt;br /&gt;&lt;br /&gt;Assessing relative efficacy of antidepressants. Bandolier Apr 2009. Disponível em: &lt;a href="http://www.medicine.ox.ac.uk/bandolier/booth/mental/cipriani.html"&gt;http://www.medicine.ox.ac.uk/bandolier/booth/mental/cipriani.html&lt;/a&gt; [acedido em 24 Mai 2009]&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-661833056052664810?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/661833056052664810/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/eficacia-relativa-de-antidepressivos.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/661833056052664810'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/661833056052664810'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/eficacia-relativa-de-antidepressivos.html' title='Eficácia relativa de antidepressivos comuns- Estaremos a fazer as melhores opções?'/><author><name>Ana Mateus</name><uri>http://www.blogger.com/profile/09316520083954362490</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://4.bp.blogspot.com/_UY1RwZ3_rqg/SiMDaDbGT4I/AAAAAAAAAAM/T2ifNV2qebU/S220/Ana_palmeira.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1508712653970104807</id><published>2009-05-30T17:27:00.000+01:00</published><updated>2009-05-30T17:29:21.349+01:00</updated><title type='text'>Genéricos comparticipados a 100% para Pensionistas</title><content type='html'>Foi publicado em Diário da República o &lt;a href="http://dre.pt/pdf1sdip/2009/05/10400/0338903390.pdf"&gt;Decreto-Lei n.º 129/2009&lt;/a&gt;, de 29 de Maio, que possibilita a comparticipação total de medicamentos genéricos, para pensionistas cujo rendimento total anual não exceda 14 vezes o salário mínimo nacional. Esta medida entra em vigor já a partir de segunda-feira, dia 1 de Junho.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1508712653970104807?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1508712653970104807/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/genericos-comparticipados-100-para.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1508712653970104807'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1508712653970104807'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/genericos-comparticipados-100-para.html' title='Genéricos comparticipados a 100% para Pensionistas'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8306462037448372157</id><published>2009-05-30T09:24:00.002+01:00</published><updated>2009-05-30T09:26:24.097+01:00</updated><title type='text'>Será a chupeta um factor de risco para a otite média?</title><content type='html'>&lt;strong&gt;Is pacifier use a risk factor for acute otitis media?A dynamic cohort study&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;Four hundred and ninety-five children between the ages of 0 and 4 years followed from 2000 to 2005 in a dynamic population study in the Leidsche Rijn residential area in Utrecht, The Netherlands. AOM was diagnosed by GPs according to the International Classification of Primary Care coding system. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.&lt;br /&gt;Pacifier use appears to be a risk factor for recurrent AOM. Parents should be informed about the possible negative effects of using a pacifier once their child has been diagnosed with AOM to avoid recurrent episodes.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://fampra.oxfordjournals.org/cgi/reprint/25/4/233.pdf"&gt;Rovers MM, Numans ME, Langenbach E, Grobbee DE, Verheij TJ, Schilder AG. Is pacifier use a risk factor for acute otitis media? A dynamic cohort study. Fam Pract. 2008 Aug;25(4):233-6. Epub 2008 Jun 17.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8306462037448372157?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8306462037448372157/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/is-pacifier-use-risk-factor-for-acute.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8306462037448372157'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8306462037448372157'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/is-pacifier-use-risk-factor-for-acute.html' title='Será a chupeta um factor de risco para a otite média?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2210391323849941905</id><published>2009-05-30T09:10:00.005+01:00</published><updated>2009-05-30T09:15:30.538+01:00</updated><title type='text'>World health statistics 2009</title><content type='html'>&lt;a href="http://4.bp.blogspot.com/_r0hEhSELnvE/SiDqbni_hXI/AAAAAAAAAEw/UE2pwFB5rfM/s1600-h/untitled.bmp"&gt;&lt;img id="BLOGGER_PHOTO_ID_5341526918254527858" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 171px; CURSOR: hand; HEIGHT: 152px; TEXT-ALIGN: center" alt="" src="http://4.bp.blogspot.com/_r0hEhSELnvE/SiDqbni_hXI/AAAAAAAAAEw/UE2pwFB5rfM/s320/untitled.bmp" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;A publicação da OMS / WHO &lt;a href="http://www.who.int/entity/whosis/whostat/EN_WHS09_Full.pdf"&gt;Estatísticas Sanitárias Mundiais&lt;/a&gt; 2009 contém dados dos 193 estados membros e incluí um sumário da evolução para a consecução das metas dos &lt;a href="http://www.who.int/entity/mediacentre/factsheets/fs290/en/index.html"&gt;Objectivos de Desenvolvimento do Milénio&lt;/a&gt; relacionados com a saúde.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2210391323849941905?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2210391323849941905/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/world-health-statistics-2009.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2210391323849941905'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2210391323849941905'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/world-health-statistics-2009.html' title='World health statistics 2009'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_r0hEhSELnvE/SiDqbni_hXI/AAAAAAAAAEw/UE2pwFB5rfM/s72-c/untitled.bmp' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7657404540750244185</id><published>2009-05-24T13:59:00.000+01:00</published><updated>2009-05-24T14:00:20.816+01:00</updated><title type='text'>Prescrição Racional</title><content type='html'>Hoje, as leituras recomendadas vão para a área da prescrição. São muitos os documentos disponíveis na Net sobre este tema. Seleccionam-se alguns que são particularmente relevantes pelo seu conteúdo e metodologia, independentemente da data de publicação.&lt;br /&gt;Pode-se aceder a um ficheiro que contém diferentes documentos sobre &lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/browse.aspx/Prescri%c3%a7%c3%a3o%20Racional"&gt;Prescrição Racional&lt;/a&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;Guide to Good Prescribing  - World Health Organization Action Programme on Essential Drugs&lt;/li&gt;&lt;li&gt;Prescribing Guide 500M – 2007&lt;/li&gt;&lt;li&gt;Manual de Prescrição Farmacológica Racional - CEMBE da FML&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Um outro documento já bem conhecido mas sempre muito útil é o &lt;a href="http://www.infarmed.pt/prontuario/prontuario_terapeutico.pdf"&gt;Prontuário Terapêutico&lt;/a&gt; que pode igualmente ser acedido &lt;a href="http://www.infarmed.pt/prontuario/index.php"&gt;online&lt;/a&gt;.&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7657404540750244185?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7657404540750244185/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/prescricao-racional.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7657404540750244185'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7657404540750244185'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/prescricao-racional.html' title='Prescrição Racional'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2314634919999275723</id><published>2009-05-23T18:30:00.003+01:00</published><updated>2009-05-23T18:44:03.433+01:00</updated><title type='text'>Formação cirurgia vascular</title><content type='html'>Irá decorrer uma Formação sobre doença venosa e arterial periférica, no auditório do HPH, dia 27 de Maio, entre as 14:30h e as 19:30h.&lt;br /&gt;  Terá conteúdo teórico, e outra parte prática de realização de eco-doppler em ambulatório, com apoio de um cirurgião vascular.&lt;br /&gt;  As inscrições são gratuitas e com direito a certificado de presença, mas só há espaço para 30 a 50 pessoas, por isso é melhor garantir vaga com inscrição prévia, através de email para Lurdes.maia@ulsm.min-saude.pt, ou por contacto telefónico para o centro de formação (Ext. 1512).&lt;br /&gt;  Como se fala que, no futuro, o ecógrafo fará parte do material indispensável nos nossos consultórios, talvez seja uma formação pertinente e útil!&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2314634919999275723?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2314634919999275723/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/formacao-cirurgia-vascular.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2314634919999275723'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2314634919999275723'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/formacao-cirurgia-vascular.html' title='Formação cirurgia vascular'/><author><name>XPina</name><uri>http://www.blogger.com/profile/02679244254910142190</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1793880346687102712</id><published>2009-05-17T22:40:00.013+01:00</published><updated>2009-05-17T23:29:14.626+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='H1N1'/><title type='text'>Ainda sobre a gripe</title><content type='html'>Uma interessante visão que compara o impacto do H1N1 à escala mundial, acompanhado pela mediatização subjacente, com a mortalidade da tuberculose no mesmo período de tempo.&lt;br /&gt;Por Hans Rosling  em &lt;a href="http://www.youtube.com/watch?v=V8bUtbODV-Q"&gt;http://www.youtube.com/watch?v=V8bUtbODV-Q&lt;/a&gt;&lt;a href="http://http//www.youtube.com/watch?v=V8bUtbODV-Q"&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1793880346687102712?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1793880346687102712/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/ainda-sobre-gripe.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1793880346687102712'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1793880346687102712'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/ainda-sobre-gripe.html' title='Ainda sobre a gripe'/><author><name>Margarida Cruz</name><uri>http://www.blogger.com/profile/04618191763413355556</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4065768020319469613</id><published>2009-05-16T11:07:00.003+01:00</published><updated>2009-05-16T13:31:17.971+01:00</updated><title type='text'>Holding chambers versus nebulisers for beta-agonist treatment of acute asthma</title><content type='html'>Nas crises agudas de asma usam-se doses mais elevadas de agonistas β2 inalados (inaladores de alívio). Os medicamentos podem ser dados através de nebulizadores ou de inaladores pressurizados com câmara expansora, A presente revisão compara os dois métodos de administração em serviços de urgência e em ambulatórios comunitários. Nos adultos, não se identificaram diferenças importantes entre os dois métodos, enquanto que em crianças, os que foram aleatorizados no grupo dos nebulizadores, passaram mais tempo no serviço de urgência. Os inaladores pressurizados (MDI) têm um desempenho equivalente aos nebulizadores na utilização de agonistas β2 inalados nas crises de asma.&lt;br /&gt;&lt;br /&gt;Cates Christopher J, Crilly Jacqueline A, Rowe Brian H. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. &lt;a href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000052/frame.html"&gt;Cochrane Database of Systematic Reviews: Reviews 2006 Issue 2 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4065768020319469613?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4065768020319469613/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/holding-chambers-versus-nebulisers-for.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4065768020319469613'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4065768020319469613'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/holding-chambers-versus-nebulisers-for.html' title='Holding chambers versus nebulisers for beta-agonist treatment of acute asthma'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1704914727703226296</id><published>2009-05-14T22:42:00.002+01:00</published><updated>2009-05-14T22:47:33.589+01:00</updated><title type='text'>The Physical Therapy Prescription</title><content type='html'>Numerous guidelines recommend physical therapy for the management of musculoskeletal conditions. However, specific recommendations are lacking concerning which exercises and adjunct modalities to use.&lt;br /&gt;&lt;br /&gt;There is some evidence that specific exercises performed with the instruction of physical therapists improve outcomes in patients with low back pain. A physical therapy prescription should include the diagnosis; type, frequency, and duration of the prescribed therapy; goals of therapy; and safety precautions.&lt;br /&gt;&lt;br /&gt;Rand SE, Goerlich C, Marchand K, Jablecki N. The Physical Therapy Prescription. American Family Physician. &lt;a href="http://www.aafp.org/afp/20071201/1661.html"&gt;Leawood: Dec 1, 2007. Vol. 76, Iss. 11; p. 1661&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1704914727703226296?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1704914727703226296/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/physical-therapy-prescription.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1704914727703226296'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1704914727703226296'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/physical-therapy-prescription.html' title='The Physical Therapy Prescription'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7908849738329391603</id><published>2009-05-10T21:18:00.000+01:00</published><updated>2009-05-10T21:19:23.199+01:00</updated><title type='text'>Physician reported perception in the treatment of high blood pressure does not correspond to practice</title><content type='html'>Um inquérito sobre a opinião dos médicos de família e internistas em relação a conhecimentos sobre as &lt;em&gt;guidelines&lt;/em&gt; sobre o tratamento da hipertensão, barreiras ao controlo da hipertensão e a auto avaliação do médico sobre o tratamento da hipertensão dos seus doentes.&lt;br /&gt;&lt;br /&gt;Constatou-se que a capacidade dos médicos para avaliar o desempenho pessoal no tratamento da hipertensão e a opinião dos médicos de que a não adesão dos doentes é a maior barreira ao controlo optimizado da hipertensão é contraditória com o comportamento referido na prática clínica.&lt;br /&gt;&lt;br /&gt;Wexler R, Elton T, Taylor CA, Pleister A, Feldman D. Physician reported perception in the treatment of high blood pressure does not correspond to practice. &lt;a href="http://www.biomedcentral.com/content/pdf/1471-2296-10-23.pdf"&gt;BMC Family Practice 2009, 10:23 (2 April 2009).&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7908849738329391603?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7908849738329391603/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/physician-reported-perception-in.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7908849738329391603'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7908849738329391603'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/physician-reported-perception-in.html' title='Physician reported perception in the treatment of high blood pressure does not correspond to practice'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-6755611048858875470</id><published>2009-05-06T23:43:00.000+01:00</published><updated>2009-05-06T23:44:19.510+01:00</updated><title type='text'>Artigos da American Academy of Family Physicians sobre Gripe</title><content type='html'>Três artigos de revisão actuais de livre acesso, publicados na revista American Family Physician e na Family Practice Management.&lt;br /&gt;&lt;br /&gt;A gripe vista sob o prisma da Medicina Geral e Familiar&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aafp.org/online/en/home/publications/journals/afp/preprint/combat-h1n1.printerview.html"&gt;Temte JL. Basic rules of influenza: how to combat the H1N1 influenza (swine flu) virus. Am Fam Physician. 2009;Preprint&lt;/a&gt;&lt;a href="http://www.aafp.org/online/en/home/publications/journals/afp/preprint/combat-h1n1.printerview.html"&gt;.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aafp.org/online/en/home/publications/journals/afp/preprint/influenza-telephone-triage.printerview.html"&gt;Temte JL. Telephone triage of patients with influenza. Am Fam Physician. 2009; Preprint&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://lyris.aafp.org/t/2258375/5522251/734361/0/"&gt;Preparing Your Office for an Infectious Disease Epidemic&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-6755611048858875470?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/6755611048858875470/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/artigos-da-american-academy-of-family.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6755611048858875470'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/6755611048858875470'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/artigos-da-american-academy-of-family.html' title='Artigos da American Academy of Family Physicians sobre Gripe'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-7047678438174123804</id><published>2009-05-06T22:23:00.003+01:00</published><updated>2009-05-06T22:45:19.425+01:00</updated><title type='text'>Influenza H1N1 (Gripe Suína)</title><content type='html'>&lt;a href="http://2.bp.blogspot.com/_r0hEhSELnvE/SgIE3PAdPEI/AAAAAAAAAEg/pxdEiJJ7zTc/s1600-h/handwash.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5332830255727852610" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 232px; CURSOR: hand; HEIGHT: 190px; TEXT-ALIGN: center" alt="" src="http://2.bp.blogspot.com/_r0hEhSELnvE/SgIE3PAdPEI/AAAAAAAAAEg/pxdEiJJ7zTc/s320/handwash.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;Um excelente artigo de revisão acessível na Medscape Family Medicine&lt;br /&gt;&lt;br /&gt;H1N1 Influenza (Swine Flu)&lt;br /&gt;&lt;a href="http://emedicine.medscape.com/article/1673658-print"&gt;http://emedicine.medscape.com/article/1673658-print&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-7047678438174123804?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/7047678438174123804/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/influenza-h1n1-gripe-suina.html#comment-form' title='1 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7047678438174123804'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/7047678438174123804'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/influenza-h1n1-gripe-suina.html' title='Influenza H1N1 (Gripe Suína)'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_r0hEhSELnvE/SgIE3PAdPEI/AAAAAAAAAEg/pxdEiJJ7zTc/s72-c/handwash.jpg' height='72' width='72'/><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-4240693104709868522</id><published>2009-05-05T22:27:00.001+01:00</published><updated>2009-05-05T22:27:46.048+01:00</updated><title type='text'>Family practice: professional identity in transition. A case study of family medicine in Canada</title><content type='html'>With increasingly fewer family physicians in many countries and students less interested in primary care careers, generalists are becoming an endangered species. This situation is a major health care resource management challenge. In a rapidly changing health care environment, family medicine is struggling for a clear identity - a matter which is crucial to health system restructuring because it affects the roles and functioning of other professions in the system.&lt;br /&gt;&lt;br /&gt; Beaulieu MD, Rioux M, Rocher G, Samson L, Boucher L. Family practice: professional identity in transition. A case study of family medicine in Canada. &lt;a href="http://d.yimg.com/kq/groups/9664677/1469971510/name/Beaulieu_Transition%28SSM_2008%29.pdf"&gt;Soc Sci Med. 2008 Oct;67(7):1153-63. Epub 2008 Jul 20&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-4240693104709868522?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/4240693104709868522/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/family-practice-professional-identity.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4240693104709868522'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/4240693104709868522'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/family-practice-professional-identity.html' title='Family practice: professional identity in transition. A case study of family medicine in Canada'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-2723888427925288108</id><published>2009-05-03T22:29:00.002+01:00</published><updated>2009-05-03T22:31:26.786+01:00</updated><title type='text'>5 de Maio - Dia Mundial da Asma 2009. “Você pode controlar a sua Asma”</title><content type='html'>&lt;a href="http://3.bp.blogspot.com/_r0hEhSELnvE/Sf4M7fpZLgI/AAAAAAAAAEI/d-PYZzNGkSg/s1600-h/WAD09LogoLowRes%5B1%5D.JPG"&gt;&lt;img id="BLOGGER_PHOTO_ID_5331713225100176898" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 164px; CURSOR: hand; HEIGHT: 168px; TEXT-ALIGN: center" alt="" src="http://3.bp.blogspot.com/_r0hEhSELnvE/Sf4M7fpZLgI/AAAAAAAAAEI/d-PYZzNGkSg/s320/WAD09LogoLowRes%5B1%5D.JPG" border="0" /&gt;&lt;/a&gt; &lt;div&gt;O dia mundial da Asma (&lt;a href="http://www.ginasthma.com/WADindex.asp"&gt;World Asthma Day&lt;/a&gt;) é um evento anual organizado pela &lt;a href="http://www.ginasthma.com/index.asp"&gt;Global Initiative for Asthma (GINA)&lt;/a&gt; com o intuito de aumentar a atenção e os cuidados da asma em todo o Mundo. &lt;/div&gt;&lt;div&gt;O dia mundial da Asma 2009 será na Terça-feira dia 5 de Maio. O tema deste ano será de novo “Você pode controlar a sua Asma”.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-2723888427925288108?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/2723888427925288108/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/5-de-maio-dia-mundial-da-asma-2009-voce.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2723888427925288108'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/2723888427925288108'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/5-de-maio-dia-mundial-da-asma-2009-voce.html' title='5 de Maio - Dia Mundial da Asma 2009. “Você pode controlar a sua Asma”'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_r0hEhSELnvE/Sf4M7fpZLgI/AAAAAAAAAEI/d-PYZzNGkSg/s72-c/WAD09LogoLowRes%5B1%5D.JPG' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8726471490364682497</id><published>2009-05-02T21:25:00.003+01:00</published><updated>2009-05-03T22:28:51.446+01:00</updated><title type='text'>Tratamento da Asma</title><content type='html'>&lt;a href="http://2.bp.blogspot.com/_r0hEhSELnvE/SfyscMEXjvI/AAAAAAAAAEA/qkIuAbEYiao/s1600-h/WAD09LogoLowRes%5B1%5D.JPG"&gt;&lt;/a&gt;  &lt;div&gt;Medicamentos e dispositivos inalatórios disponíveis no mercado Português para o tratamento da asma.&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/browse.aspx/Asma"&gt;Ver documentos&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8726471490364682497?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8726471490364682497/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/dia-mundial-da-asma-2009-voce-pode.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8726471490364682497'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8726471490364682497'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/dia-mundial-da-asma-2009-voce-pode.html' title='Tratamento da Asma'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3739324649850237791</id><published>2009-05-02T21:19:00.000+01:00</published><updated>2009-05-02T21:20:40.827+01:00</updated><title type='text'>The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey</title><content type='html'>Estudo transversal que compara a pontuação do ACT e a classificação de controlo da asma segundo o GINA.&lt;br /&gt;Uma pontuação &lt;19 no ACT é útil para a identificação de doentes com asma mal controlada, de acordo com a definição do GINA.&lt;br /&gt;&lt;br /&gt;Thomas M, Kay S, Pike J, Williams A, Rosenzweig JRC, Hillyer EV, Price D. The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. &lt;a href="http://www.thepcrj.org/journ/vol18/18_1_41_49.pdf"&gt;Prim Care Resp J 2009;18(1):41-49&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3739324649850237791?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3739324649850237791/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/asthma-control-test-act-as-predictor-of.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3739324649850237791'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3739324649850237791'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/asthma-control-test-act-as-predictor-of.html' title='The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-246015074764623835</id><published>2009-05-01T23:32:00.008+01:00</published><updated>2009-05-02T21:48:44.894+01:00</updated><title type='text'>Influenza A(H1N1): Special Highlights</title><content type='html'>&lt;a href="http://2.bp.blogspot.com/_r0hEhSELnvE/Sft5UZAjzxI/AAAAAAAAADw/5_yq2PHn5K4/s1600-h/untitled.bmp"&gt;&lt;img id="BLOGGER_PHOTO_ID_5330987975140691730" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 154px; CURSOR: hand; HEIGHT: 136px; TEXT-ALIGN: center" alt="" src="http://2.bp.blogspot.com/_r0hEhSELnvE/Sft5UZAjzxI/AAAAAAAAADw/5_yq2PHn5K4/s320/untitled.bmp" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;p&gt;&lt;a href="http://www.who.int/entity/csr/disease/swineflu/en/index.html"&gt;A situação continua a evoluir. 13 países já notificaram oficialmente 365 casos de influenza A(H1N1).&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.who.int/entity/csr/resources/publications/Adviceusemaskcommunity.pdf"&gt;Advice on the use of masks in the community setting in Influenza A (H1N1) outbreaks&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Gripe%2009/Situation%20Report%20020509.pdf"&gt;ECDC Situation Report Influenza A(H1N1) infection Update 2 May 2009&lt;/a&gt;&lt;a href="http://www.who.int/entity/csr/resources/publications/Adviceusemaskcommunity.pdf"&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-246015074764623835?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/246015074764623835/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/influenza-ah1n1-special-highlights.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/246015074764623835'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/246015074764623835'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/05/influenza-ah1n1-special-highlights.html' title='Influenza A(H1N1): Special Highlights'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_r0hEhSELnvE/Sft5UZAjzxI/AAAAAAAAADw/5_yq2PHn5K4/s72-c/untitled.bmp' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5021111491881944451</id><published>2009-04-29T22:28:00.015+01:00</published><updated>2009-05-03T19:04:35.749+01:00</updated><title type='text'>Doença humana pela nova estirpe do vírus da gripe A(H1N1)</title><content type='html'>&lt;a href="http://4.bp.blogspot.com/_r0hEhSELnvE/SfjHyupTDqI/AAAAAAAAADg/rKb0qw40skU/s1600-h/i009718.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5330229833321615010" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 248px; CURSOR: hand; HEIGHT: 127px; TEXT-ALIGN: center" alt="" src="http://4.bp.blogspot.com/_r0hEhSELnvE/SfjHyupTDqI/AAAAAAAAADg/rKb0qw40skU/s320/i009718.jpg" border="0" /&gt;&lt;/a&gt; A DGS apresenta as recomendações do ECDC (Centro Europeu para a Prevenção e o Controlo das Doenças) para a definição de caso de doença humana pela nova estirpe do vírus da&lt;br /&gt;gripe A(H1N1) e documentos relativos à doença humana pela nova estipe do vírus da gripe (H1N1) [&lt;em&gt;ver site da DGS/microsite da gripe - &lt;/em&gt;&lt;a href="http://www.dgs.pt/" send="true"&gt;&lt;em&gt;www.dgs.pt&lt;/em&gt;&lt;/a&gt;&lt;em&gt; em constante actualização&lt;/em&gt;]&lt;br /&gt;&lt;ul&gt;&lt;li&gt;Definição de caso&lt;/li&gt;&lt;li&gt;Fluxograma de decisão para profissionais&lt;/li&gt;&lt;li&gt;Procedimentos a adoptar pelos serviços de saúde (ver actualizações no site) &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/browse.aspx/Gripe%2009"&gt;Ver documentos&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5021111491881944451?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5021111491881944451/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/definicoes-de-caso-de-doenca-humana.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5021111491881944451'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5021111491881944451'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/definicoes-de-caso-de-doenca-humana.html' title='Doença humana pela nova estirpe do vírus da gripe A(H1N1)'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_r0hEhSELnvE/SfjHyupTDqI/AAAAAAAAADg/rKb0qw40skU/s72-c/i009718.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8120286194272114823</id><published>2009-04-27T19:04:00.005+01:00</published><updated>2009-05-02T08:46:00.508+01:00</updated><title type='text'>mort@lidades</title><content type='html'>&lt;strong&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;Aplicações Informáticas da ARS-N&lt;/span&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;A mortalidade é considerada uma medida directa das necessidades em cuidados de saúde, reflectindo a carga global da doença na população, não só em termos da incidência da doença, como da capacidade de a tratar. Daí a importância dos indicadores de mortalidade no processo de planeamento da saúde e dos serviços de saúde. Tendo por objectivo estudar a mortalidade na região Norte no período de 2001 a 2005 foram desenvolvidas três aplicações informáticas que permitem aceder, de um modo simples e amigável, a informação relevante sobre mortalidade.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Conte%C3%BAdos/Sa%C3%BAde%20P%C3%BAblica%20Conteudos/PDF_AM0105_0.pdf"&gt;Mortalidade geral e específica&lt;/a&gt;&lt;br /&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Conte%C3%BAdos/Sa%C3%BAde%20P%C3%BAblica%20Conteudos/PDF_MP0105_0.pdf"&gt;Mortalidade proporcional&lt;/a&gt;&lt;br /&gt;&lt;a href="http://portal.arsnorte.min-saude.pt/portal/page/portal/ARSNorte/Conte%C3%BAdos/Sa%C3%BAde%20P%C3%BAblica%20Conteudos/PDF_ME0105_0.pdf"&gt;Mortalidade evitável&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8120286194272114823?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8120286194272114823/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/mortlidades.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8120286194272114823'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8120286194272114823'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/mortlidades.html' title='mort@lidades'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-5025560404431800811</id><published>2009-04-26T11:47:00.004+01:00</published><updated>2009-05-02T11:37:41.925+01:00</updated><title type='text'>Surto de Gripe Suína no México</title><content type='html'>As notícias estão aí nos media. Amanhã, serão os nossos doentes a virem às consultas assustados e fazerem perguntas sobre o risco e possibilidade de doença.&lt;br /&gt;&lt;br /&gt;Para estarmos mais informados …&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Swine influenza - Statement by WHO Director-General, Dr Margaret Chan&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;The current situation constitutes a public health emergency of international concern. However, more information is needed before a decision could be made concerning the appropriateness of the current alert level.&lt;br /&gt;&lt;br /&gt;WHO is coordinating the global response to human cases of swine influenza A (H1N1) and monitoring the corresponding threat of an influenza pandemic. Information on this page tracks the evolving situation and provides access to both technical guidelines and information useful for the general public. &lt;a href="http://www.who.int/csr/disease/swineflu/en/index.html"&gt;Ver&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Comunicado aos médicos do Director-Geral da Saúde e Comunicado do Director-Geral da Saúde de 2009-04-26 &lt;a href="http://www.dgs.pt/"&gt;Informação para viajantes e medidas de higiene pessoal a adoptar&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.who.int/entity/csr/swine_flu/swineflu_qanda_20090425.pdf"&gt;Swine influenza frequently asked questions&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.cdc.gov/swineflu/pdf/keyfacts.pdf"&gt;CDC page on swine flu&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://ultimahora.publico.clix.pt/noticia.aspx?id=1376662"&gt;Perguntas e respostas sobre gripe suína&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-5025560404431800811?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/5025560404431800811/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/surto-de-gripe-suina-no-mexico.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5025560404431800811'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/5025560404431800811'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/surto-de-gripe-suina-no-mexico.html' title='Surto de Gripe Suína no México'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-1763043499051918343</id><published>2009-04-26T09:21:00.020+01:00</published><updated>2009-12-28T22:15:51.842Z</updated><title type='text'>Educação Médica Contínua 2009</title><content type='html'>&lt;strong&gt;&lt;em&gt;19 Fevereiro 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%2019-2-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;Estudos de investigação:&lt;br /&gt;1. Monitorização ambulatória da pressão arterial na gravidez&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Joana Melo Cabrita, Marlene Sousa&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;2. Consultas relacionadas com DPOC dos utentes da Rede Médicos Sentinela 2007&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Jaime Correia de Sousa, Ana Margarida Cruz, Joana Melo Cabrita&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;12 Março 2009&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20ICPC-2%2012-3-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;Formação&lt;br /&gt;&lt;p&gt;1. Abordagem do registo médico orientado por problemas&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Jaime Correia de Sousa, Ana Mateus&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;2. Codificação utilizando a ICPC-2 &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Consensos para as consultas de rotina dos programas de saúde (Saúde Infantil, Saúde Materna...)&lt;/li&gt;&lt;li&gt;Discussão de dúvidas de codificação com base em casos clínicos reais&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;em&gt;1 Abril 2009&lt;/em&gt;&lt;/strong&gt; &lt;/p&gt;&lt;p&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%201-4-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;1. Estudo de investigação: Hipertensão Arterial nos adolescentes Portugueses. Prevalência e factores de risco&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Silva L, Guerra E, Bernardino P, Hahn O, Rajão R, Batista M.&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;2. Journal Club – Artigo de revisão:&lt;br /&gt;&lt;a href="http://www.aafp.org/afp/20090215/297.html"&gt;Evidence for the use of intramuscular injections of outpatient practice&lt;/a&gt; Shatksy M. Am Fam Physican. 2009; 79(4): 297-300.&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Alexandra Pina, Ana Figueiredo, Clara Pinto Ferreira&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;3. Folheto informativo: Cólicas do bebé – conselhos úteis&lt;br /&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;em&gt;Maria Espírito Santo, Rosa Santos&lt;/em&gt;&lt;br /&gt;&lt;/span&gt;4. Formação: Registo médico orientado por problemas e ICPC-2&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Discussão de dúvidas de codificação com base em casos clínicos reais&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;em&gt;28 Abril 2009&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%2028-4-09.doc"&gt;Tema&lt;/a&gt;&lt;/p&gt;Journal club&lt;br /&gt;&lt;br /&gt;1. Myint PK, Luben RN, Wareham NJ, Bingham SA, Khaw KT. Combined effect of health behaviours and risk of first ever stroke in 20 040 men and women over 11 years’ follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study. BMJ 2009;338:b349.&lt;br /&gt;&lt;a href="http://www.bmj.com/cgi/reprint/338/feb19_2/b349"&gt;http://www.bmj.com/cgi/reprint/338/feb19_2/b349&lt;/a&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Joana &lt;/span&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Cabrita&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(51, 102, 102);"&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;2. Kelly JD, Fawcett DP, Goldberg LC. Assessment and management of non-visible haematuria in primary care. BMJ 2009;338:a3021&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, Alexandra Pina, Clara Ferreira&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;3. Estágio no estrangeiro – Relato de uma experiência&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Tânia Colaço&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;29 Maio 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%2028-4-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Revisão Baseada na Evidência&lt;br /&gt;1. Lombalgia não-específica em CSP: qual o melhor tratamento?&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Margarida Cruz, Ana Calafate&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Journal club&lt;br /&gt;2. Eficácia relativa de antidepressivos comuns - Estaremos a fazer as melhores opções?&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Mateus&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;Assessing relative efficacy of antidepressants. Bandolier Apr 2009. Disponível em: &lt;a href="http://www.medicine.ox.ac.uk/bandolier/booth/mental/cipriani.html"&gt;http://www.medicine.ox.ac.uk/bandolier/booth/mental/cipriani.html&lt;/a&gt; [acedido em 24 Mai 2009]&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;25 Junho 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%2025-6-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Protocolo de Investigação&lt;br /&gt;Factores de Risco para Incontinência Urinária de Esforço&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Alexandra Pina, Ana Figueiredo, Clara Pinto Ferreira, Hermínia Teixeira, Isabel Ribeiro, Irene Lopes, Sandrina Rodrigues&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;15 Outubro 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%c3%b5es%20USF%20Horizonte%202009/Acta%20Reuni%c3%a3o%20Forma%c3%a7%c3%a3o%2015-10-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Estudo de Investigação&lt;br /&gt;Interrupção voluntária da gravidez – dois anos no Hospital Pedro Hispano&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Clara Pinto Ferreira, Alexandra Machado, Alexandra Pina, Ana Margarida Cruz&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Formação&lt;br /&gt;Prescrição racional de antibióticos nas infecções respiratórias&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Luís Silva&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;26 Novembro 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202009/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2026-11-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Formação&lt;br /&gt;Como efectuar uma pesquisa na Internet&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Jaime Correia de Sousa&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;strong&gt;&lt;em&gt;17 Dezembro 2009&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Reuni%C3%B5es%20USF%20Horizonte%202009/Acta%20Reuni%C3%A3o%20Forma%C3%A7%C3%A3o%2017-12-09.doc"&gt;Tema&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Revisão Baseada na Evidência&lt;br /&gt;N-Acetilcisteína no tratamento da DPOC&lt;br /&gt;&lt;em&gt;&lt;span style="color: rgb(0, 102, 0);"&gt;Ana Figueiredo, Isabel Ribeiro, Nuno Figueiras Alves&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Formação&lt;br /&gt;Formação Médica Contínua&lt;br /&gt;&lt;span style="text-decoration: underline;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-1763043499051918343?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/1763043499051918343/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/proxima-reuniao-de-formacao-na-usf.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1763043499051918343'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/1763043499051918343'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/proxima-reuniao-de-formacao-na-usf.html' title='Educação Médica Contínua 2009'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8112860906157361673</id><published>2009-04-26T08:54:00.001+01:00</published><updated>2009-04-26T08:56:35.334+01:00</updated><title type='text'>American Family Physician’s Series on Finding Evidence and Putting It into Practice</title><content type='html'>&lt;p&gt;(…)&lt;br /&gt;If family physicians don’t keep asking and answering clinical questions, their knowledge base will grow increasingly out of step with current practice, and their patients will suffer. But it isn’t enough to find just any answer; it should reflect the best patient oriented evidence, have the potential to change practice for the better, and improve important clinical outcomes. There is a rich body of literature advising physicians on how to ask and answer questions. Too often, though, it has encouraged physicians to focus on PubMed searches and the original research literature, a time consuming and sometimes frustrating process.&lt;br /&gt;(…)&lt;br /&gt;I propose a different skill set that prioritizes making the practicing family physician an informed consumer of the secondary literature (e.g., evidence-based guidelines, systematic reviews, critical appraisals, validated decision-support tools. The physician must become an expert at assessing the quality of an information source. Does the information focus on patient-oriented outcomes? Is it truly evidence based, or does it merely have a lot of references? Is it free of industry or other special interest bias? Does it summarize information in a way that makes it easy to access and apply at the point of care?&lt;br /&gt;&lt;br /&gt;Ebell M. AFP’s Series on Finding Evidence and Putting It into Practice. AF. Am Fam Physician. 2009;79(1):7-8.&lt;br /&gt;&lt;br /&gt;Trata-se de uma série de 6 artigos dos quais já foram publicados quatro.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Keeping Up with the Medical Literature: How to Set Up a SystemShaughnessy AF. Am Fam Physician. 2009; 79(1):25-26&lt;/li&gt;&lt;li&gt;How to find answers to clinical questionsM H Ebell. Am Fam Physician. 2009;79(4):293-296&lt;/li&gt;&lt;li&gt;Diagnosis: Making the Best Use of Medical Data&lt;br /&gt;M H Ebell. Am Fam Physician. 2009;79(6):478-480&lt;/li&gt;&lt;li&gt;Evaluating and Understanding Articles About Treatment&lt;br /&gt;Shaughnessy AF. Am Fam Physician. 2009;79(8):668-670.&lt;br /&gt; &lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8112860906157361673?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8112860906157361673/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/american-family-physicians-series-on.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8112860906157361673'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8112860906157361673'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/american-family-physicians-series-on.html' title='American Family Physician’s Series on Finding Evidence and Putting It into Practice'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-8340269792625610035</id><published>2009-04-22T00:42:00.001+01:00</published><updated>2009-05-02T11:42:25.389+01:00</updated><title type='text'>Investigação em CSP: para onde avançar?</title><content type='html'>No 26º Encontro Nacional de Clínica Geral, em Vilamoura, reflectiu-se sobre eixos prioritários de acção para alcançar o objectivo de colocar os centros de saúde portugueses num lugar de destaque, ao nível da investigação, numa sessão organizada pelo Núcleo de Investigação da Associação Portuguesa de Médicos de Clínica Geral (APMCG).&lt;br /&gt;&lt;br /&gt;Entre os oradores convidados estiveram Jaime Correia de Sousa (médico na USF Horizonte e docente da Escola de Ciências da Saúde da Universidade do Minho - UM), Clara Fonseca (membro do Núcleo de Investigação da APMCG, directora do Internato de MGF da Zona Norte e responsável pelo sector de investigação na mesma Coordenação de Internato), Yonah Yaphe (médico de família, membro do EURACT e assistente convidado da Escola de Ciências da Saúde da UM) e Paulo Nicola (Unidade de Epidemiologia do Instituto de Medicina Preventiva da Faculdade de Medicina de Lisboa). A moderação da mesa ficou a cargo de outro elemento do Núcleo de Investigação da APMCG, Carlos Canhota.  &lt;a href="http://www.jmfamilia.com/index.php?option=com_content&amp;amp;task=view&amp;amp;id=669&amp;amp;Itemid=27"&gt;Ver notícia&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-8340269792625610035?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/8340269792625610035/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/investigacao-em-csp-para-onde-avancar.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8340269792625610035'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/8340269792625610035'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/investigacao-em-csp-para-onde-avancar.html' title='Investigação em CSP: para onde avançar?'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-7402045834388658693.post-3110198629961514461</id><published>2009-04-21T23:36:00.001+01:00</published><updated>2009-05-02T11:53:53.291+01:00</updated><title type='text'>Patient Empowerment</title><content type='html'>Duas comunicações apresentadas em 2007 no &lt;em&gt;16th International Bled Course, Slovenia: September 18-22, 2007&lt;/em&gt; "&lt;a href="http://cid-4379a1a3078a50d3.skydrive.live.com/self.aspx/Patient%20Enablement/Patient%20enablement%20-%20management%20of%20chronic%20diseases.pdf"&gt;Learning and Teaching about Patient Empowerment in General/Family Practice&lt;/a&gt;".&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7402045834388658693-3110198629961514461?l=paralemdohorizonte.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://paralemdohorizonte.blogspot.com/feeds/3110198629961514461/comments/default' title='Enviar comentários'/><link rel='replies' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/patient-empowerment.html#comment-form' title='0 Comentários'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3110198629961514461'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/7402045834388658693/posts/default/3110198629961514461'/><link rel='alternate' type='text/html' href='http://paralemdohorizonte.blogspot.com/2009/04/patient-empowerment.html' title='Patient Empowerment'/><author><name>Jaime Correia de Sousa</name><uri>http://www.blogger.com/profile/05083709874489770938</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='21' src='http://3.bp.blogspot.com/_r0hEhSELnvE/Sd-YJ8BGqjI/AAAAAAAAAAU/iw9x2PksYBM/S220/encontro_%2520investigacao_3.jpg'/></author><thr:total>0</thr:total></entry></feed>
